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CHAPTER 1 
INTRODUCTION 
L l General introduction 
In the western world gallstones are a common finding in adults. Epidemiologic studies 
in Italy [1-3] reported the prevalence of gallstones to be between 8.3% [1] and 13.9% 
[3]. The prevalence increases with age and is higher for females. Over the age of 50 
years the prevalence is 10-15% for males and 20-25% for females [4]. Although 80% 
of the subjects with gallstones are free of symptoms [3], gallstone disease is a major 
health problem. It is reported to be one of the most common causes of hospitalization 
for surgical procedures [5]. In the United States 500,000 - 600,000 cholecystectomies 
are performed annually with an estimated cost of over 1 billion dollars [5]. 
Cholecystectomy has a hospital stay of approximately 5 days and a subsequent 
significant disability of 3-6 weeks. It is a safe and effective procedure and has been the 
standard therapy for more than 100 years. McSherry [6] recently reviewed records of 
more than 14,000 cases over half a century of surgically treated patients with gallstones. 
The total mortality rate was I. 7% with age being the most important risk factor. The 
mortality rate was 0.4% in patients under 50 years, !.5% in patients between 50 and 65 
years and 4.5% in patients 65 years and older. When elective cholecystectomy was 
performed the mortality rate was 0.09% for patients under 50 years and 0.8% for 
patients over 50 years. 
For medico-economic reasons and due to the relative increase in the number of older 
patients, increasing efforts are made to treat gallstone disease without the distress of 
surgery. Initial experiments in this field were made with oral bile acids for dissolution 
of cholesterol stones. Chenodeoxycholic acid (CDCA) was introduced in the early 
1970's [7]. Its mechanism is based on suppressing an enzyme of the liver for the 
synthesis of cholesterol, resulting in desaturation the bile of cholesterol and ultimate 
dissolution of gallstones [8]. The results however, proved disappointing. 
In a multicenter prospective double-masked study of the National Cooperative 
Gallstone Study Group [9] complete dissolution of stones after 2 years administration of 
CDCA was achieved in only 13.5% of the patients. Reported dose-related side effects 
were diarrhea in up to 50%, hepatotoxicity in 3% and a 10% or more elevation of 
serum cholesterol level in 85% of the patients. CDCA is now largely replaced by, or 
combined with, another litholytic bile acid, ursodeoxycholic acid (UDCA) which is 
11 
Chapter 1 
better tolerated, has fewer side effects [8], and is more effective than CDCA [8]. 
In a double-blind randomized study, Edinger et al [10] reported an efficacy rate of 
28.9% after one year administration of UDCA. Adequate results of oral bile acid 
therapy are, however, only expected in highly selected groups of patients with success 
rates of about 60% for patients with a small number of stones measuring less than 1 em 
and in 80-90% of the patients with floating stones, as assessed by oral cholecystography 
[11]. 
A major stimulant for non-invasive gallstone treatment was the introduction of extra 
corporeal shockwave lithotripsy (ESWL) [12, 13]. This method to fragment stones uses 
shockwaves that are generated with different techniques such as electrostatic spark 
discharge, electromagnetic shockwaves and pulsed piezoelectric shock generation. The 
shockwaves are generated under water and transmitted to the stones through a water 
bath or, recently, a water-filled cushion and through body soft tissue. ESWL is non-
invasive, only i. v. analgesia is needed, and the procedure can be performed on 
outpatient basis. The first machines were developed for the treatment of kidney stones 
and soon unleashed a revolution in the management of urolithiasis [14-16]. 
With the first reported results of the use of ESWL for gallbladder stones from a 
group in Munich (FRG), it became evident that ESWL also plays a part in the 
management of gallstone disease [17,18]. These researchers formulated strict criteria for 
the selection of patients with symptomatic gallstone disease. The most important are: (1) 
A solitary radiolucent gallbladder stone measuring up to 30 mm in diameter, or no more 
than three stones with a similar total stone mass. (2) The gallbladder has to be 
visualized on oral cholecystography. By these criteria, only 28% of the patients they 
screened were eligible for ESWL. All their patients received adjuvant oral bile acids (a 
combination of CDCA and UDCA), which started 2 weeks before ESWL and continued 
for 3 months after complete clearance of stone fragments. ESWL combined with oral 
bile acids appeared effective, especially for patients with solitary stones up to 20 mm, 
95% was stone free after 12-18 months. Patients with 2 or 3 stones were stone free 
after 12-18 months in 67% of cases. Side effects of ESWL were reported as minimal 
and can be related to the shockwave therapy itself i.e., energy trauma. They are usually 
mild and limited to transient microscopic hematuria (3%) and cutaneous petechiae at the 
entry site of the shockwaves (14%) [18]. On the other hand, the migration of stone 
fragments may also lead to complications. Episodes of biliary pain occurring before the 
disappearance of stone fragments was reported by 35% of the patients. Mild pancreatitis 
was observed in two patients (1 %), one of which required endoscopic sphincterotomy to 
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extract the fragments from the common bile duct [18]. 
The group from Munich, in summarizing their results, concluded that ESWL is safe 
and effective in selected patients. Unfortunately their favorable results have not yet been 
duplicated by other investigators [19-24]. The less favorable outcomes of others may be 
caused by several factors: Burhenne and coworkers [19,20] did not use adjuvant oral 
bile acids and also include calcified gallstones. They used a more vigorous ESWL 
regime, retreating patients with stone fragments larger than 3 mm. (the Munich protocol 
only retreats stone fragments larger than 5 mm). Sixty-one percent of their cases was 
stone free after I year. Patients with a solitary stone were stone free in 70% of the 
cases. Den Toom et al [21] and Zeman et al [22] strictly followed the Munich treatment 
protocol, but, expanded the inclusion criteria concerning the number and size of the 
stones. Only 30% of their patients was stone free after I year. However, even when the 
results of the group of patients with solitary stones are considered, the clearance rate is 
still lower (54%) compared to the Munich study. 
The Dornier National Biliary Lithotripsy study [23,24] was designed to determine 
the value of adjuvant oral bile acids. The selection criteria proclaimed by the Munich 
study were employed, but, the number of delivered shockwaves was decreased. After 6 
months only 21% of their patients treated with ESWL combined with oral bile acids 
were free of stones (Munich study: 63%) and 35% of the patients with solitary stones 
(Munich study: 78%). 
It is unclear to what extent the use of different equipment with different shockwave 
generating techniques contributed to the differences in outcome of therapy [25]. 
Although many questions concerning the outcome of therapy have to be answered, it is 
evident that patient selection is crucial [26]. The best results are obtained in patients 
with a solitary radiolucent stone less than 20 mm in diameter (70-95% stone free after 
1-2 years). 
Local contact dissolution, another way to treat gallstones by dissolving gallstones with 
pharmaceutical agents, gained attention during the experiments with ESWL. 
Experiments with local contact dissolution were initially developed for retained bile 
duct stones [27]. The first clinical application of a safe and effective cholesterol solvent 
mono-octanion was published by Thistle and co-workers in 1980 [28]. The method has 
not gained wide spread application because of the slow dissolution rate of mono-
octanion (1-20 days) and due to the introduction of endoscopic retrograde 
cholangiography with sphincterotomy, which largely replaced other treatments for 
(retained) bile duct stones. A promising new option for local contact dissolution was 
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introduced by Allen and coworkers from the Mayo Clinic [29], who reported rapid 
dissolution of gallbladder stones by methyl tert-butyl ether (MTBE). 
Diethyl ether, an anesthetic, was known to dissolve gallstones rapidly but its 
volatilization was an insurmountable problem for clinical application. A derivate MTBE 
boils at 55° C, remains liquid at body temperature and is therefore more stable than 
diethyl ether. The solvent is introduced through a percutaneous transhepatic gallbladder 
catheter. Both the agent and the percutaneous approach make this procedure a more 
invasive and hazardous one compared to oral bile acids and ESWL. 
A group of investigators from the Mayo Clinic, recently reported favorable results in 
75 patients with cholesterol stones [31]. They did not limit the number and size of 
gallstones. The average time of treatment was 5 hours per day for 1 to 3 days. 
Complete or more than 95% dissolution was achieved in 72 of 75 patients (96%) and 
side effects or complications were few. Most patients required i. v. analgesics during the 
first hours of therapy, one third of the patients complained of transient nausea with or 
without emesis. In one patient serious overflow of MTBE from the gallbladder to the 
bile ducts and systematic absorption of MTBE was observed with clinical signs of 
ulcerative duodenitis and hemolysis. Sixteen percent of the patients had abdominal pain 
after removal of the catheter, probably due to slight transient leakage of bile. One 
patient suffered hypotension and bradycardia at the time the gallbladder was punctured, 
and responded well to anticholinergic medication. It was concluded by the Mayo Clinic 
group that percutaneous MTBE contact dissolution is a useful alternative to surgery in 
selected patients with symptomatic cholesterol stones of the gallbladder. 
In addition to the above mentioned forms of treatment, there is a range of more invasive 
therapeutic possibilities, consisting of several percutaneous techniques to remove 
gallstones from the gallbladder and/or bile ducts [32-37]. The indications for these 
techniques are usually limited to patients at high risk for general anesthesia and the 
morbidly obese. A new and relatively less invasive technique for percutaneous stone 
removal is rotatory gallstone cholecystolithotripsy [37]. A small impeller is introduced 
into the gallbladder to pulverize the indwelling gallstones. First reported results in a 
limited number of patients are promising with minor complications [37]. 
All nonsurgical treatments of gallstone disease have the preservation of the gallbladder 
in common. Although many patients (and fewer physicians) consider this an advantage, 
potential risks remain. 
First, by staying intact, the gallbladder may form recurrent gallstones. Although 
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long-term follow-up is not yet available, a recurrence rate of about 30% within 3 years 
after oral bile acid therapy [38,39] and after local contact dissolution with MTBE is 
reported [40]. The Munich group [41] reported a lower recurrence rate after ESWL 
(11% after 18 months), probably because they treated a highly selected population with 
up to 80% patients with solitary stones [39,42]. 
Another risk associated with gallbladder preserving treatments for gallstone disease 
is the possible development of carcinoma of the gallbladder [ 43]. Gallbladder carcinoma 
has been reported to occur in 0.5-1.5% of patients who underwent cholecystectomy 
[43]. Large gallstones [44] and calcified or "porcelain" gallbladders [45] are associated 
with an increased risk for gallbladder carcinoma therefore, in these cases, 
cholecystectomy is recommended. 
At present nonsurgical treatments of gallstone disease do not only have to compete with 
standard open cholecystectomy but also with laparoscopic cholecystectomy [46,47]. This 
technique, first performed in 1987 by Mouret in France [48], uses endoscopic 
equipment which was initially developed for gynecologic purposes. After small incisions 
four sheaths are introduced at different sites of the abdomen. One sheath in the 
umbilical region is used to allow introduction of a gas insufflator to create a 
pneumoperitoneum and followed by a video-laparoscope. Two sheaths are placed in the 
right upper quadrant to allow introduction of surgical instrumentation. A sheath in the 
epigastrium is used to dissect the cystic duct and cystic artery from the surrounding 
tissue and to remove the gallbladder from the hepatic fossa. The gallbladder is finally 
extracted through the umbilical incision. 
The advantages of laparoscopic cholecystectomy, compared to standard open 
cholecystectomy, were stated by Soper [49]: less postoperative pain; diminished 
hospitalization (mean hospital stay 1-2 days) [47] and interval of disability; improved 
cosmetics. The disadvantages are: three-dimensional depth perception is limited by the 
monocular vision of the video laparoscope; most general surgeons are unfamiliar with 
laparoscopic techniques; poor visualization of the common bile duct and inability to deal 
adequately with common bile duct stones which are discovered during the procedure. 
The Southern surgeons club [47], in a prospective study of 1518 patients who 
underwent laparoscopic cholecystectomy, reported seven injuries (0.5%) to the common 
bile duct or the hepatic duct during the procedure. In standard open cholecystectomy the 
frequency of bile duct injuries is estimated at 0.1-0.2% [49]. Another possible 
disadvantage is the difficulty to control hemorrhages. 
The Southern surgeons club [47] reported a complication rate of 5.1% which 
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compares favorably with the complication rates reported for standard open 
cholecystectomy. Laparoscopic cholecystectomy is considered a major surgical 
procedure, carrying with it risks similar to those of conventional cholecystectomy. 
According to Soper [50], the absolute contraindications for laparoscopic 
cholecystectomy are patients unable to tolerate general anesthesia and patients with 
cholangitis, peritonitis and coagulopathy. The relative contraindications include severe 
obstructive pulmonary disease, acute cholecystitis, common bile duct stones, previous 
upper abdominal surgery, advanced liver disease, known abdominal malignancy, large 
gallstones (> 4 em), morbid obesity and pregnancy. 
It is expected that laparoscopic cholecystectomy will become the preferred surgical 
therapy for gallstone disease. Thus, nonsurgical treatments of gallstone disease should 
be compared to the new standard: laparoscopic cholecystectomy [48]. Further 
investigations are needed to establish the definite position for the different nonsurgical 
treatment modalities [51 ,52]. 
Nevertheless, nonsurgical gallstone therapy has fundamentally changed the role of 
radiology in the management of gallstone disease, both diagnostically and inter-
ventionally. Aspects of this new role are described in this thesis. 
L2 Diagnostic Imaging of Patients with Gallstone Disease 
Before the advent of nonsurgical treatment of gallstones, most patients with 
symptomatic gallstones were treated surgically by cholecystectomy. This procedure was 
indicated when gallstones were established either by ultrasonography or by oral 
cholecystography. Information concerning the nature of the stones, their size and 
number was not really necessary. Today, when nonsurgical treatment is considered, this 
specific information is mandatory. Moreover, diagnostic imaging plays a role during 
ESWL treatment and after nonsurgical treatment, to assess the efficacy and safety of the 
procedure. 
L2.l Diagnostic imaging before nonsurgical therapy 
In patients with gallstones, the selection of those suitable for treatment with nonsurgical 
therapy is crucial to obtain favorable results. Diagnostic imaging plays an important role 
in the selection of treatment for patients with symptomatic gallstone disease. It is 
necessary to be informed about the number, size and chemical composition of the 
gallstones as well as about the functional state of the gallbladder itself [53]. 
16 
Introduction 
Table 1.1 gives an outline of the selection criteria for the currently available 
treatments of gallstone disease and indicates the possible radiologic examinations to 
assess these criteria. 
The aim of this part of the thesis was to design an imaging strategy for patients with 
symptomatic gallstone disease. A comparative study of the various radiologic 
examinations that may be used to assess the selection criteria are presented in chapters 
2, 3 and 4. 
1.2.2 Diagnostic imaging during ESWL 
The first generation of lithotriptors was specifically designed to treat kidney stones. 
Because kidney stones are usually radiopaque, targeting of the stones was done under 
fluoroscopic controL The current multipurpose machines are equipped with both 
fluoroscopy and ultrasound (US) for targeting. 
In lithotripsy of gallbladder stones only US is used for targeting. Precise targeting is 
very important and is considered the most difficult element in lithotripsy of gallbladder 
stones [52,54-56]. It includes initial localization of the stone(s), choice of a safe and 
effective shockwave path, constant monitoring of the stone(s) and frequent retargeting 
[56,57,58]. Ultrasonography during ESWL can be hampered by shockwave related 
artifacts, such as cavitation bubbles which can mimic fragmentation of stones [59,60]. 
Effective fragmentation of gallbladder stones by ESWL is therefore highly dependent on 
the US experience and knowledge of cross-sectional anatomy of the treating physician 
[51]. 
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Table 1.1 Treatments of symptomatic gallbladder stones: selection criteria and radiologic assessment 
Selection 
criteria 
gallstones 
present/absent 
stone size 
number of stones 
stone composition 
cholesterol/pigment 
stone calcification 
patent cystic duct 
concentration 
capability of the 
gallbladder 
contractility 
of the gallbladder 
anatomy of the 
gallbladder 
US = ultrasonography 
OCG = oral cholecystography 
CT = computed tomography 
18 
Oral 
bile acids 
present 
< 10 mm 
small number 
cholesterol 
nn 
yes 
yes 
not mandatory 
indifferent 
ESWL 
present 
5-30 mm 
I - 3 
cholesterol 
small rim 
accepted 
yes 
yes 
not mandatory 
safe shock-
wave path 
Contact 
dissolution 
MTBE 
present 
unlimited 
unlimited 
cholesterol 
no 
yes 
indifferent 
not mandatory 
safe access 
route 
Percutaneous 
stone removal 
present 
unlimited 
unlimited 
indifferent 
indifferent 
yes 
indifferent 
indifferent 
safe access 
route 
Laparoscopic 
chokcystec-
to my 
present 
< 4 em 
unlimited 
indifferent 
indifferent 
indifferent 
indifferent 
indifferent 
no adhesions 
no variants 
Introduction 
Open 
cholecystec-
to my 
present 
unlimited 
unlimited 
indiff..:rent 
indifferent 
indifferent 
indifferent 
indifferent 
indifferent 
radiological 
examination 
US, (OCG) 
OCG, US 
OCG, US 
plain abdominal 
film, OCG. CT 
plain abdominal 
film, OCG, CT 
OCG, chole-
scintigraphy, US 
OCG 
US, cholescinti-
graphy, (OCG) 
US,CT 
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1.2.3 Diagnostic imaging after nonsurgical therapy 
All nonsurgical treatments of gallstone disease have the preservation of the gallbladder 
in common. Follow-up of patients treated in this way is necessary. Firstly, to assess the 
efficacy of the specific therapy, which can be determined by the rate of fragmentation 
or the rate the stones are cleared from the gallbladder, and later, to detect possible 
recurrence of stones. Secondly, to assess complications of the treatment, which could be 
related to the treatment itself (e.g. energy trauma in case of ESWL) or to the migration 
of stone fragments from the gallbladder to the duodenum. U1trasonography is 
considered the diagnostic modality of choice in the follow-up of patients after treatment. 
Evaluation of US findings in the follow-up of patients treated with ESWL, with 
focus on its reliability in the assessment of efficacy, is discussed in chapter 6. 
1.3 Interventional Radiology in Patients with Gallstone Disease 
Radiological interventional techniques play a major role in nonsurgical therapy of 
gallbladder stones. A short review of radiological interventional techniques for 
cholecystostomy is presented in chapter 7 and several techniques for percutaneous 
fragmentation and removal or direct contact dissolution of gallstones are described. 
A major drawback of nonsurgical treatments of gallstones, with subsequent 
preservation of the gallbladder, is the potential for recurrent gallstones [38-42]. These 
can be prevented by chemical ablation of the gallbladder by percutaneous administration 
of sclerosing agents [63-65]. Combining percutaneous treatment of stones with 
subsequent sclerotherapy of the gallbladder can offer a possible alternative for surgical 
treatment of gallstone disease. 
Chapter 8 describes a one-step procedure, in which stone treatment and sclero-
therapy of the gallbladder can be combined. 
20 
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THE VALUE OF ULTRASOUND IN PREDICTING NON-
VISUALIZATION OF THE GALLBLADDER ON OCG: 
Implications for Imaging Strategies in Patient Selection for 
Nonsurgical Therapy of Gallstones 
2.1 Abstract 
Gallbladder visualization on Oral Cholecystography (OCG) is required for most 
nonsurgical therapies of gallstones. In this study we attempted to establish sonographic 
criteria which will predict non-visualization of the gallbladder on OCG. For this 
purpose we compared the results of ultrasound (US) and OCG in 171 patients with 
gallstones, being assessed for nonsurgical therapy. Sonographic criteria for non-
visualization were a contracted gallbladder and stone impaction in the gallbladder neck 
or cystic duct. In detecting findings which predict non visualization on OCG, US had a 
sensitivity of 78.3% and a specificity of 97.6%. The predictive values were: positive 
findings 92.3% and negative findings 92.4%. The overall accuracy was 92.4% 
We conclude that US can be used as a first step in selecting patients for nonsurgical 
therapy and if US indicates a contracted gallbladder, 11% of the patients can be 
excluded from further diagnostic imaging. 
2.2 Introduction 
During the past 10 years, patients suspected of having gallstone disease have been 
predominantly evaluated by Ultrasound (US), which has become the most reliable 
method for detecting gallstones and has bypassed the use of oral cholecystography 
(OCG) [!]. With the concept of nonsurgical treatment, such as extracorporeal 
shockwave lithotripsy (ESWL), oral dissolution and local dissolution of stones, the role 
of diagnostic imaging modalities has become more demanding in selecting symptomatic 
patients [2]. Additional information about number, size and chemical composition of 
gallstones is needed. 
Published as: Koen Brake!. M.D., Johan S. Lameris, M.D .. Huub G.T. Nijs, M.D .. Abida Z. Ginai, 
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Moreover, visualization of the gallbladder on OCG is required because this ensures 
cystic duct patency and concentration capability of the gallbladder. This last issue is 
mostly responsible for a revival of oral cholecystography (OCG). 
In this study we attempted to establish sonographic criteria which will predict non-
visualization of the gallbladder on OCG. For this purpose we compared OCG and US 
findings in the assessment of patients with symptomatic gallstone disease for nonsurgical 
therapy in a blinded prospective way. 
2.3 Materials and Metbods 
From April 1988 to June 1989, 171 consecutive patients (36 male, 135 female, mean 
age 51, ± 15 SD; range 22-85) with symptomatic gallstones underwent US and OCG as 
part of their selection for nonsurgical treatment of gallstones. Ultrasound and OCG 
were performed in the fasting state on the same day by different radiologists. The data 
were recorded on standardized forms by the performing radiologists, without knowledge 
of the results of previous examinations. OCG was performed after oral intake of 4g 
iocetamic acid (Cholebrine®, Dagra Pharma, Diemen, The Netherlands), the evening 
before the examination. The radiologist had to assess the gallbladder visualization and 
categorize it as absent or present. 
Toshiba, Aloka or Philips real time US equipment were used for sonography with 
3.5 MHz or 5 MHz curved array and sector transducers. Sections of the gallbladder 
were obtained in different planes and in supine, left posterior oblique and erect positions 
of the patient. 
Within the scope of this study the following US findings were recorded: 
l The size and the shape of the gallbladder, i.e. normal, contracted or hydropic. A 
gallbladder was considered contracted when the gallbladder lumen only contained calculi 
without normal surrounding bile. Hydrops was assumed when the transverse diameter 
of the gallbladder measured more than 4.5cm [3]. 
2 The stones could be located in the cystic duct, the gallbladder neck, in the body or in 
the fundus. Impaction could be present or absent. Impaction was considered present 
when stones did not move with change in patient position, especially in the erect 
position. 
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3 Additional findings such as: 
(!) Generally thickened gallbladder wall 
(> 3mm). Possible features were also 
recorded in order to explain the 
thickening of the gallbladder wall, such 
as chronic cholecystitis, adenomyo-
matosis, cholesterolosis or additional 
pathology associated with the thickened 
gallbladder wall [4]. In the case of 
contracted gallbladders no thickness 
was measured. 
(II) Sludge (a layer of low echoes 
within the gallbladder, changing its 
position very slowly with gravity [5]. 
Non-visualization of the gallbladder on 
OCG was predicted by the following 
US findings:(!) A contracted 
gallbladder (Fig.!), (2) Impacted 
gallstone(s) in the cystic duct or the 
gallbladder neck (Fig.2). 
Figure 2.1 Typical example of WES triad (wall. 
echo,shadow) which is the most specific sign of a 
contracted stone-filled gallbladder [1]. 
Frgure 2.2 (a) Gallstone in gallbladder neck and sludge ball. (b) Same patient in erect position: the 
gallstone is impacted in the gallbladder neck and the sludge is lying on the bottom of the gallbladder. 
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Table 2.1 US findings compared with gallbladder visualization on OCG 
US findings 
Contracted 
gallbladder * 
Stone impaction * 
Negative findings 
Gallbladder 
visualization 
on OCG 
Absent 
Present 
Absent 
Present 
Absent 
Present 
Number of 
patients 
19 
19 
3 
10 
122 
173* 
additional 
US findings 
Sludge (n~2) 
Sludge (n=S) 
Hydrops (n~2) 
General thickened gallbladderwall (n= I) 
Sludge (n=3) 
Adenomyorna.tosis (n= 1) 
*Two patients had both contracted gallbladder and stone impaction (173 findings in 171 patients). 
2.4 Results 
The US and OCG findings are recorded in Table I. In three cases impacted stones were 
observed sonographically, but these stones probably did not obstruct the duct complete-
ly, allowing the gallbladder to be visualized on OCG. In 10 other cases, although no 
specific sonographic findings were noted, the gallbladder was not visualized on OCG. 
One of these patients was diagnosed on US as having a polyp (diameter 5mm) in the 
gallbladder neck (lying on dependent wall with no acoustic shadow and no movement 
with changing the patient's position). However, computed tomography showed a dense 
calculus in the gallbladder neck (the diagnosis was confirmed by cholecystectomy). 
Within the group of patients with stone impaction and non-visualization on OCG 
(N = 19), eight had additional US findings, such as sludge (N =5), hydrops (N =2) and 
one patient a generalized thickened gallbladder wall. Sludge was also found in two 
patients with contracted gallbladders and in three patients with visualization of the 
gallbladder and no other US findings. One patient had a generally thickened gallbladder 
wall on US, which was suspected as due to adenomyomatosis. This diagnosis was 
supported by OCG findings. 
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Table 2.2 Comparison of ultrasound with oral cholecystography 
OCG visualization absent 
OCG visualization present 
Total 
Ultrasound 
positive findings 
36 (True positive) 
3 (False positive) 
39 
Ultrasound 
negative findings 
10 (False negative) 
122 (True negative) 
132 
Total 
46 
!25 
171 
Table 2 shows the comparison of US with OCG. In detecting findings which will 
predict non visualization on OCG. US had a sensitivity of 78.3% and a specificity of 
97.6%. The predictive values were: positive findings 92.3% and negative findings 
92.4%. The overall accuracy was 92.4%. 
2.5 Discussion 
Non-visualization of the gallbladder on OCG is an exclusion criterion for extracorporeal 
shockwave lithotripsy (ESWL) and oral dissolution of gallstones. Only in the case of 
local contact dissolution therapy gallbladder visualization is not mandatory [6]. This 
study shows that ultrasound (US) can provide important information about this selection 
criterion. 
We realize that non-visualization of the gallbladder on OCG is a troublesome finding 
since many non-biliary causes may be responsible [7]. Due to logistical reasons we were 
not able to provide repeat doses in cases of non-visualization. However, in most of the 
patients in whom a repeat dose resulted in normal visualization, the initial dose had 
given a faint visualization of the gallbladder [8]. Therefore, we categorized patients 
with faint visualization as visualization being present. 
In our material 26.8% of the gallbladders with gallstones were not visualized on 
OCG. This is in accordance with the literature [9] suggesting that our data concerning 
OCG are reliable. 
We did not use a fatty meal, either with OCG or with US because the response of 
the gallbladder to a fatty meal is too variable to permit valid conclusions regarding the 
ability of the gallbladder to empty normally [10]. Nevertheless Bellamy et al [11] 
reported a positive correlation between gallbladder visualization on OCG and 
contraction of the gallbladder on US after a fatty meal. 
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All gallbladders that appeared contracted on US were not visualized on OCG. From 
the 22 patients in whom an impacted stone was diagnosed sonographically, three 
gallbladders were nevertheless visualized on OCG, probably due to incomplete 
obstruction of the cystic duct. There were 10 false-negative cases, in which the 
gallbladder was not visualized on OCG and in which the gallbladder did not show 
abnormalities (except gallstones) on US. 
Based on previous reports [1,4,5], sonographic signs, such as hydrops, thickening of 
the gallbladder wall and sludge, were considered as non-specific findings. Nevertheless 
sludge and hydrops respectively were found relatively more in patients with either a 
contracted gallbladder or stone impaction and non-visualization of the gallbladder on 
OCG (nine out of 36 patients) than in patients without a contracted gallbladder or stone 
impaction and present visualisation of the gallbladder on OCG (three out of 122 
patients). In our opinion these additional findings increase the positive predictive value 
of the more specific US findings. 
When sonographic findings such as a contracted gallbladder are used as a criterion 
for chronic cholecystitis (lack of concentration capability) and stone impaction in the 
gallbladder neck or cystic duct as a criterion for non-patency of the cystic duct, US has 
a high specificity (97.7%) and a high positive predictive value (92.3%) in predicting 
non-visualization of the gallbladder on OCG. Moreover, in contrast with OCG, it 
indicates the cause of non-visualization. This may influence the imaging strategy when 
patients are being selected for nonsurgical therapy of gallstones. 
In the case of a contracted gallbladder no further diagnostic imaging is needed (no 
false-positive findings) and nonsurgical therapy is not indicated. 
In the case of stone impaction the strategy is more complicated. First there are a few 
patients with partial obstruction of the cystic duct, who have normal gallbladder 
visualization on OCG (false-positive findings). Moreover, even with complete 
obstruction and a non-visualized gallbladder on OCG there could be a role for ESWL, 
since such therapy may re-establish cystic duct patency. When US findings do not 
indicate suspicion that a non-visualized gallbladder will exist on OCG, one should 
proceed with OCG, in order to avoid false-negative results. 
We conclude that US, being the first diagnostic modality for detecting gallstones, 
can also be used as a first step in selecting patients for nonsurgical therapy of gallstones 
and if US indicates a contracted gallbladder, 11% of the patients can be excluded from 
further diagnostic imaging. 
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CHAPTER3 
ACCURACY OF ULTRASOUND AND ORAL CHOLECYS-
TOGRAPHY IN ASSESSING THE NUMBER AND SIZE OF 
GALLSTONES: Implications for nonsurgical therapy 
3.1 Abstract 
Prior to nonsurgical therapy of gallstones it is important to assess the number and size of 
gallstones. In order to evaluate the accuracy of ultrasound (US) and oral cholecystography 
(OCG) to count and measure gallstones a prospective blind study was conducted to 
compare the results of US (N = 99) and OCG (N = 36), either alone or in combination (N 
= 34), with the number and size of gallstones retrieved after cholecystectomy. The 
number of gallstones was accurately estimated by US and OCG in 74% and 69% of the 
cases, respectively. In assessing the presence of up to 3, 5 or 10 gallstones both US and 
OCG proved reliable. In measuring the size of gallstones, there was 19% accuracy with 
US compared to only 3% with OCG. With an accepted measurement error of 3 mm these 
values increased to 80% for US and 44% for OCG. 
US proved more reliable than OCG in discriminating gallstones smaller or larger than 
10 mm and smaller or larger than 20 mm, but with US detection of gallstones larger than 
30 mm was problematic. With both US and OCG there was underestimation of gallstone 
size. The combination of both techniques did not significantly improve the assessment of 
either number or size of gallstones compared to the results obtained with US or OCG 
alone. It is concluded that I) both US and OCG have some limitations in assessing the 
number and size of gallstones, 2) the combination of both examinations does not improve 
the results, 3) patient selection for nonsurgical therapy of gallstones can be started with US 
alone. 
Accepted for publication as: Koen Brakel, M.D .. Johan S. Lam~ris. M.D .. Huub G.T. Nijs. M.D .. Abida Z. 
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3.2 Introduction 
With the introduction of nonsurgical therapy of gallstones, the demands for diagnostic 
imaging of gallstone disease have changed. It is no longer sufficient to establish only the 
presence of gallstones. In order to select the proper nonsurgical treatment, information is 
also needed about the number, size and chemical composition of gallstones and about the 
functional status of the gallbladder [1]. 
The primary imaging modalities for gallstone disease are ultrasound (US) [2] and oral 
cholecystography (OCG) [3,4]. US has certain limitations in assessing the number and size 
of gallstones [1,5-8], whereas OCG is reported to be more appropriate in this respect [4]. 
The aim of this investigation was to evaluate the accuracy of US and OCG, in combination 
or alone, in assessing the number and size of gallstones. For this purpose we compared, in 
a prospective blind study, the results of US and OCG with the number and size of 
gallstones retrieved after cholecystectomy. 
3.3 Materials and Methods 
From April 1988 till May 1990, 99 patients (22 male, 77 female, mean age 52 years, 
range 20-83) with symptomatic gallstone disease underwent ultrasound (US) and oral 
cholecystography (OCG) as part of their diagnostic workup for selection for nonsurgical 
treatment of gallstones. The patients underwent cholecystectomy either because they were 
randomized to operation in our on-going trial lithotripsy vs cholecystectomy [9] or because 
they did not meet the criteria for lithotripsy [9]. US and OCG were performed in the 
fasting state on the same day by different radiologists and data were recorded on standar-
dized forms, without knowledge of the results of the other examination. Ultrasonography 
was performed with real-time equipment (Toshiba, Aloka) with 3.5 MHz or 5.0 Mhz 
curved array and sector transducers. Sections of the gallbladder were obtained in different 
planes with patients in supine, left posterior oblique and erect positions. OCG was 
performed after oral intake of 4 g iocetamic acid (Cholebrine®, Dagra Pharma B.V., 
Diemen, The Netherlands) the evening before the examination. OCG examinations 
included supine, prone oblique and erect spot films of the gallbladder, made during 
fluoroscopy on a buc!..-y table. Only examinations with diagnostically sufficient opacifi-
cation of the gallbladder (N = 36) were included. When both US and OCG examinations 
were available for the same patient (N = 34), the largest diameter and largest number of 
gallstones recorded, were considered as the outcome of the combined examinations. After 
cholecystectomy, the gallbladder content was collected for analysis. 
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Only stones with a diameter of ~ 3 mm were counted. The numbers of gallstones were 
categorized as 1, 2, 3, 4, 5, 6-10 or more than 10 stones. Only the largest gallstone was 
measured. In case of non-spherical stones the largest diameter was recorded. Measure-
ments of stone size by OCG was corrected for an empirically determined magnification 
factor of 1.3. 
Data analysis 
The percentage correct was defined as 100 times the proportion of US or OCG which 
agreed with the post-operative results, divided by the total number of examinations. This 
proportion is referred to as the positive predictive value. Percentages correct were 
compared using a standard test to compare two proportions assuming a binomial distri-
bution [10]. Receiver-operating characteristic (ROC) graphs [11] were used to compare 
the efficacy of US and OCG to predict gallstone sizes at various cutoff points. 
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3.4 Results 
The results are presented in Figures 3.1 to 3.5. Figure 3.1 shows the correctly assessed 
numbers of gallstones on US, OCG and the results of the combined techniques based on 
the examination revealing the largest number of stones. The number of gallstones was 
accurately estimated by US and OCG in 74% and 69% of the cases, respectively. In 
assessing the presence of 2, 3, 4 or 5 gallstones OCG was slightly, but not significantly, 
more accurate than US: 67% and 44%, respectively. The results did not improve signifi-
cantly when US and OCG were used in combination. 
In assessing the presence of up to 3, 5 or 10 stones the results obtained with US and 
OCG were similar. Again, combined US and OCG did not significantly improve the 
results (Figure 3.2). 
Figure 3.3 shows accuracy of US and OCG in measuring gallstone diameter and the 
results of the combined techniques for which the largest measured diameter was used in 
the analysis. There was 19% accuracy with US compared to only 3% with OCG; with an 
accepted measurement error of 3 mm the percentage correct increased to 80% for US and 
44% for OCG; with an accepted error of 5 mm the percentage increased to 87% for US 
and 79% for OCG. For up to 4 mm measurement error these results are significantly 
better for US compared to OCG (p < 0.05). The combination of US and OCG did not 
improve these results compared to either examination performed alone. 
The results of the diameter measurements on US were independent of number of stones. 
Percentages correct of the predicted measurements on US were not significantly different 
when the gallstone population was divided into single vs multiple st9nes, ll!' to 3 vs more 
than 3 stones, or up to 5 vs more than 5 stones. The stone population was also divided into 
stones up to 15 mm in diameter (N = 58) vs larger than 15 mm (n = 37). In assessment of 
stone diameter US was proved significantly better (P < 0.05) with stones up to 15 mm 
than for larger stones, irrespective of the accepted measurement error. 
Figure 3.4 shows ROC graphs for discriminating gallstone size with US (Figure 3.4a) 
and OCG (Figure 3.4b) at various cut-offpoints. Since the entire curve for US lies closer 
to the upper left corner than the curve for OCG, US has more discriminating power than 
OCG, irrespective of the cut-off points. Nevertheless, US missed 2 out of 3 cases in 
detecting gallstones larger than 30 mm. 
Figure 3.5 shows differences in postoperative measurements of gallstone diameter 
compared with US (Figure 3.5a) and OCG (Figure 3.5b). Both US and OCG underes-
timate gallstone size. 
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3.5 Discussion 
This study compared the accuracy of US and OCG to assess the number and size of 
gallstones. To our knowledge this has not been described previously. The results show 
some limitations for both US and OCG, either alone or in combination. 
With US there were problems in assessing the precise number of stones in the presence 
of 2- 10 stones, which confirms the suggestion by other investigators [I] that US appears 
to be less accurate in counting stones. With OCG the estimation was slightly more 
accurate with 2 - 5 stones, but the overall results in assessing the number of gallstones 
were similar to those with US. Simeone and co-workers suggested to perform both US and 
OCG and to consider the examination revealing the largest number of gallstones to be 
correct. As the results of this study did not improve using this method, we can not support 
their conclusion. Selection criteria for biliary lithotripsy vary in the number of stones that 
can be treated [9,12-14]. Although in this study both US and OCG showed limitations in 
counting numbers of stones, these techniques can be used as tools to select patients, 
independent of the number of stones that are accepted for treatment. (Figure 3.2) 
In assessing stone size, US becomes more reliable with an accepted measurement error 
of 3 mm, while OCG reaches a reliable standard only at an accepted error of 5 mm. Wben 
taking the largest measured diameter on US or OCG as the correct diameter, the results in 
this study did not improve, this in contrast to a report by others [1]. 
In measuring stone size both US and OCG underestimate size and detecting stones larger 
than 30 mm was problematic with US. This is important, because most protocols for 
biliary lithotripsy exclude stones larger than 30 mm. Unfortunately this study had no OCG 
examinations with stones larger than 30 mm, proven postoperatively. US and OCG 
accuracy to count and measure gallstones will be influenced by patient, technical and 
observer related factors. For example in obese patients the use of 5 MHz transducers in 
ultrasonography is limited and can be a cause of less accurate measurements [8]. Obesity 
will also influence the effect of radiographic magnification on OCG examinations. 
In this study the measurements were corrected with a magnification factor of 1.3 for all 
OCG examinations, independent of the weight of the patient, which could have contributed 
to the less accurate measurements obtained on OCG. In addition the stone burden and 
composition of the stones can influence the level of accuracy. With US stones can be 
hidden in the acoustic shadow of other stones and axial measurements, which are more 
accurate than transverse measurements, are not always possible. Similarly OCG can miss 
small and slightly calcified stones or underestimate the size if a calcified rim is missed. 
The quality of US examination is highly dependent on the expertise of the investigator [7] 
as is OCG; moreover OCG has not been used during the last decade. All examinations 
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were made under routine conditions by different radiologists and therefore this study 
reflects common radiological practise. 
Based on the results of this and a previously published study [15], some guidelines are 
suggested for imaging strategies in patient selection for biliary lithotripsy. In our opinion 
there are two main options: 
1 Patient selection starts with US examination. Patients with a contracted gallbladder 
(11% in our previously published study) [15] are excluded because this US finding has 
proven to be highly specific in predicting non-visualization of the gallbladder on OCG-
[15]. In case of stone impaction in the gallbladder neck or cystic duct (13% in our 
previously published study) [15] which also reliably predicts non-visualization on 
OCG, there could however be a role for lithotripsy, because this therapy could re-
establish cystic duct patency. Patients with more than 3 (45% in this study), 5 (34%) or 
10 (24%) stones are excluded depending on the chosen protocol for lithotripsy. 
The remaining patients ( 44%, 55% or 65% according to the accepted number of stones) 
should undergo OCG for the following reasons: 
I To avoid false negative results concerning non-visualization of the gallbladder as 
predicted with US. 
II To get information about the chemical composition of gallstones, although OCG has 
limitations for this purpose. Buoyancy is a specific sign for cholesterol stones but 
unfortunately it is an infrequent finding. Radiolucency c.q. radiopacity is unreliable 
in distinguish cholesterol stones from pigment stones and computed tomography has 
proven to be more reliable for predicting gallstone composition [16]. 
2 The other option is to perform both US and OCG on the same day and consider it as one 
examination. Although this option has logistical advantages, the results of this study 
indicate that this will not improve the outcome and, therefore, some patients ( 44% -
65%) will be unnecessarily subjected to OCG. 
It is concluded that 1) both US and OCG have some limitations in assessing the number 
and size of gallstones, 2) the combination of both examinations does not improve the 
results, 3) patient selection should start with US which would exclude ± 50% of the 
patients for biliary lithotripsy. 
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PREDICTING GALLSTONE COMPOSITION Wim CT: 
In Vivo and in Vitro Analysis 
4.1 Abstract 
Chemical composition of gallstones is of major importance in selecting patients for 
nonsurgical therapy. In a combined in vivo and in vitro study of predictive potential, 50 
patients undergoing cholecystectomy were evaluated with computed tomography (CT) and 
either plain abdominal radiography or oral cholecystography (OCG). The largest stone 
surgically removed from each patient was subjected to in vitro CT and chemical analysis. 
The authors found an inverse relationship between CT attenuation numbers and cholesterol 
content and a good positive correlation between CT attenuation numbers and calcium 
content. In vivo CT analysis improved sensitivity, specificity, accuracy, and positive and 
negative predictive values compared to plain abdominal radiography and OCG in detection 
of cholesterol stones. Using their prediction rule (a CT number smaller than 140 HU 
indicates a pure cholesterol gallstone), the authors correctly classified gallstones in 17 
(84%) of another 20 patients. In vivo CT analysis can enable reliable prediction of 
gallstone composition and should play an important role in the selection of patients for 
nonsurgical treatment. 
4.2 Introduction 
The success of nonsurgical treatment of gallstones is highly dependent on patient selection. 
One of the major selection criteria is the chemical composition of the stones. With the 
advent of oral and local contact dissolution agents, accurate estimates must be made 
regarding cholesterol and calcium content of the stones, because the best results are to be 
expected in stones with high cholesterol and low calcium content. Until now, the single 
radiographic criterion for assessment of cholesterol stones has been radiolucency. 
However, the predictive value of this feature is low[!]. 
Published as: Koen Brakel, M.D., Johan S. Lamt:ris, M.D .. Huub G.T. Nijs. M.D .. Onno T. Terpstra. 
M.D., Gerard Steen. M.Sc., Bert G. Blijenberg. Ph.D .. PREDICTING GALLSTONE COMPOSITION 
WITH CT: In Vivo and in Vitro Analysis. Radiology 1990:174:337-341. 
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Therefore, investigators have been searching for radiographic features that can enable 
prediction of the composition of gallstones more precisely [2-9]. Ultrasonography seems 
to be of little value [3-4]. In vitro analysis with computed tomography (CT) is promising 
[6-9] and has encouraged us to perform a combined in vivo and in vitro study to evaluate 
the validity of in vivo CT analysis in predicting gallstone composition. In this report. 
results of in vivo and in vitro CT analysis are compared with findings from plain abdomi-
nal radiography and oral cholecystography (OCG). The chemical analysis of the gallstone 
composition served as the standard of reference. 
4.3 Patients and Methods 
Fifty consecutive unselected patients (37 women and 13 men aged 23-82 years; mean age 
52 years, ± 12, (standard deviation, SD)) including one with congenital spherocytosis, 
underwent elective cholecystectomy between May 1988 and December 1988. All were 
evaluated preoperatively with plain abdominal radopgraphy (n = 29) or OCG (n = 21) 
and CT (n=50). After operation the largest gallstone was maintained in sterile saline 
solution and analyzed by means of CT. Thereafter chemical analyses were performed. 
Patients followed diet instructions the day before all examinations and were in the 
fasting state, during all exminations. 
Plain abdominal radiographs were made with the patient supine; collimated views of 
the right upper quadrant were obtained at a setting of 65-75 kV. OCG was performed after 
intake of eight tablets of 500 mg iocetamic acid (Cholebrine®, Mallinckrodt, St. Louis). 
No scout radiograph was obtained. Fluoroscopic examinations were made with the patients 
supine and erect to include spot images of the gallbladder. For plain abdominal radio-
graphy as well as for OCG, radiopacity was defined as present or absent without regard to 
location within the stones. 
CT scans were obtained with a Tomoscan 350 (Philips Medical Systems, Eindhoven, 
The Netherlands), at settings of 120 kV and 200 rnA and included contiguous sections of 
12-mm thickness through the area of the gallbladder and, if stones were detected, 
contiguous sections of 3-mm thickness through the largest stone. No contrast material was 
given. In vitro CT examinations included contiguous sections of 3-mm and 1.5-mm 
thickness, made through a cylindric Plexiglass phantom containing eight chambers filled 
with physiologic saline solution. 
At examination, gallstones were categorized as calcified or noncalcified. Calcified 
stones were subdivided into three groups: only a calcified rim (type I), only a calcified 
core (type II) or other (type III). Noncalcified stones were subdivided into two groups: 
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detectable (type IV) (including soft tissue attenuation, isoattenuating with a soft-tissue-
attenuation rim and hypoattenuating) and nondetectable (type V) (isoattenuating with 
surrounding bile). 
For both in vivo and in vitro CT studies, a reference calibration phantom containing 
water and serial dilutions of dipotassium hydrogen phosphate K2HPO, [10] and a body 
phantom were used to compensate and/or correct for the different CT variables. For 
quantitative CT analysis we used a specially developed technical factor set. 
Patients were scanned while they lay prone on the calibration phantom, which was in 
contact with the right upper abdominal wall. The calibration phantom was attached in vitro 
to the cylindric Plexiglass phantom. To enable comparison of our results with results from 
other CT systems, our CT numbers were converted to equivalent values of milligrams of 
K2HPO, per milliliter, with the method described by Cann and Genant [10]. 
For CT analysis the following method was used (Fig.4.1). A 3-mm section with the 
maximum diameter of the largest stone was chosen for the assessment of the CT number. 
This ensures that, in analysis of stones with a calcified rim or core, a proportional part of 
the rim or core is included. After magnification of the image by a factor of four we chose a 
representative region of interest that encompassed the outline of the stone. The effect of 
volume averaging was minimized by avoiding the margins of the stone. However, for 
rimmed gallstones this would imply exclusion of the outerpart of the rim. Therefore we 
encompassed the complete outline of the rimmed stone. 
Gallstones undetected at CT examination were considered to have attenuation values 
similar to those of bile (8- 33 HU) (in vivo) or saline solution (10- 15 HU) (in vitro). 
CT analysis was carried out by one of the authors (K.B.). To estimate intraobserver 
variations, five randomly selected stones were analyzed 10 times at different dates. The 
coefficient of variation was below 5%. 
4.3.1 Chemical analysis 
Gallstones were washed, dried superficially, and weighted to the nearest 0.1 g. After 
drying to constant weight ( 48 hours at 37° C) the stones were weighed again to calculate 
water content. Gallstones were ground in a mortar, and 40 mg of the resulting powder was 
transferred to a 15-ml glass tube. Ten milliliters of ethanol was added, and the closed 
tubes were incubated at 50° C for 10 minutes to complete the dissolution of cholesterol. 
After standing at room temperature for another 10 minutes, the tubes were centrifuged at 
2,000 g for 10 minutes. Then the cholesterol level was determined according to the 
method of Abell eta! [11]. 
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Figure 4.1 CT scans of patien in prone position illustrate our method of analyzing gallstones. Four steps are 
n~ssary to assess a CT number:(a) We obtained a 12-m.m section through the area of the gallbladder that 
shows a gallstone. (b) Then we obtained a 3-mm section through the largest diameter of the gallstone. (c) We 
enlarged b four times. (d) Then we selected the region of interest (A). 
Twenty-five milligrams of gallstone powder was transferred to a 50 ml volumetric 
flask. Five drops of concentrated HCl were added, and after 1 minute, 1 ml of water was 
added. After 1 more minute the flask was filled to volume with water. After fLltration the 
calcium content was analyzed using an o-cresolphtalein complexion method [12] on an 
EPOS 5060 instrument (Merck, Eppendorf, Hamburg, Germany). 
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Figure 4.2 Gallstone types in vivo. Patients are 
in prone position. (a) A stone with only a cal-
cified rim (type I). (b) A stone with only a cal-
cified core (type II). (c) Other calcified (type 
III). (d) A noncalcified, detectable stone with 
soft-tissue attenuation (type IV). (e) A noncal-
cified, undetectable stone (type V). 
47 
Chapter 4 
4.3.2 Data analysis 
Relationship between CT numbers and chemical composition were investigated with the 
Spearman's rank-correlation test. Receiver-operating characteristic graphs [13] were used 
for comparing tests. We chose this modus of presentation because it illustrates well the 
compromise one must make between the sensitivity and the specificity of different tests, 
both being independent of disease prevalence. The best test is the one lying closest to the 
upper left corner of the plot. 
This study was approved in March 1988 by the Medical Ethics Committee of the Erasmus 
University I University Hospital Dijkzigt, Rotterdam, The Netherlands. 
Table 4.1 Chemical analysis of ~allstones in 50 patients 
Type of gallstone 
Pure cholesterol 
('2!80% cholesterol) 
Mixed 
(~25%-80% cholesterol) 
Pigment stones 
( < 25% cholesterol) 
Number 
37 
5 
8 
Note: Numbers in parentheses indicate range. 
4.4 Results 
Percentage of 
Cholesterol ± SD 
91.6 ± 5.3 (80-100) 
68.0 ± 9.0 (55-78) 
5.0 ± 7.8 ( 0- IS) 
pt!rcentage of 
Calcium± SD 
2.0± 1.8(0.0-7.4) 
8.! ± 5.8 (0.4-14.0) 
!6.1 ± 10.2(0.0-28.5) 
The mean stone diameter was 15mm (range, 3-33). Table 4.1 shows the chemical analysis 
of the gallstones. We divided the stones into three groups, depending on cholesterol 
content: pure cholesterol gallstones (;, 80% dry cholesterol weight), mixed gallstones 
(;, 25% and < 80%) and pigment gallstones ( < 25%). 
Table 4.2 shows the distribution of the different types of gallstone (I-V) in vivo (Fig. 
2) and in vitro, with the average CT number for each type. The in vivo distribution closely 
resembles the in vitro distribution. Twelve stones were not detected in vivo (type Y). Four 
of these were visualized in vitro and classified as type !Y (noncalcified, detectable). 
The individual CT numbers in vivo and in vitro showed a good correlation (r = .98) 
(Fig.4.3). 
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Table 4.2 Distribution of gallstone types at CT in vivo and in vitro 
Type Characteristic 
Calcified rim 
II Calcified core 
No. of Gallstones~ 
(n =50) 
In Vitro In Vivo 
13 (26) 14 (28) 
2 (4) (2) 
Mean CT Numbers¢ (HU) 
In Vitro In Vivo 
109 (62-303) 106 (40-309) 
51 (42-64) 50 (50) 
Ill Other Calcified 17 (34) 17 (34) 392 (105-1028) 389 (83-1120) 
IV Noncalcified. 
ddectable 10 (20) 6 (12) 56 (53-58) 49 (46-51) 
v Noncalcified. 
not detectable 8 (16) 12 (24) 12 (10-15) 18 (8-33) 
Numbers in parentheses are percentages. 
¢ Numbers in parentheses indicate range. 
Figures 4.4 and 4.5 show a good correlation between CT attenuation numbers and chol-
esterol and calcium content. The in vivo results are similar to the in vitro results. After 
analysis of these data, we defined 
a cutoff point for pure cholesterol 
stones at 140 HU with a range of 
135-145 HU (the "safety zone"), 
so that the specificity and sen-
sitivity were maximized. 
No relationship was found 
between size of gallstones and 
ability to predict their compo-
ition. The cholesterol content 
correlation coefficient of all stones 
(n = 50) was 0.80, and for stones 
10 mm or larger(n = 37) it was 
0. 78. The calcium content cor-
relation coefficient for all stones 
and for stones 10 mm or larger 
was 0.93. 
C -~T_n~u~m~b~e~r~(H~)~;~n~v~;v~o~------------, 120or 
1000 
800 
600 
400 
r• 0.98 
' 
" 
' 
/ 0 
~ ' 
200 ~ / 
;v/ :J 
Iii'~ 
0,~~~--~------~--~---
0 200 400 600 800 1000 1200 
CT number (H) In vitro 
Figure 4.3 Comparison of the individual CT numbers in 
vivo and in vitro. 
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Table 4.3 shows the comparison of CT analysis with the classiccriteria of radiolucency and 
radiopacity. Both in vivo and in vitro CT analysis improved the predictability of gallstone 
composition in comparison with plain abdominal radiography or OCG. Most striking is the 
improvement in the negative predictive value: from 50% for plain radiograph or OCG to 
83.3% for CT in vivo and even to 100% for CT in vitro. 
Table 4.3 Results of radiologic examinations for classification of gallstones 
Plain Abdominal 
Radiography 
orOCG 
Ind~x 
Cholesterol content :2=: SO% 
Cholesterol content <SO% 
Lucent 
28 
4 
Sensitivity(%) 75.7 
Specificity(%) 69.2 
Accuracy(%) 74.0 
Positive predictive value(%) 87.5 
Negative Predictive value ( %) 50 
Opaqu~ 
9 
9 
CT in Vivo 
(mean total) 
,;;J40HU >140HU 
35 2 
3 10 
94.6 
76.9 
90.0 
92.1 
83.3 
CT in Vitro 
(mean total) 
,;;140HU >140HU 
37 0 
3 10 
100 
76.9 
94.0 
92.5 
100 
Because the prediction rule (a CT number smaller than 140 HU indicates a pure 
cholesterol stone) was determined retrospectively, we tested the usefulness of this rule 
prospectively in another 20 patients. Seventeen stones (84%) were correctly classified in 
vivo with this rule. 
4.5 Discussion 
To our knowledge, in vivo CT analysis of gallstones has not previously been described. 
Our in vivo results closely resemble in vitro results. This confirms the validity of the in 
vivo analysis. 
Quantitative CT analysis for characterization of gallstones, like all quantitative CT 
studies, is complicated by CT number instability due to technical and geometrical factors 
[14]. The use of a reference calibration phantom compensates for the instability of our CT 
numbers over time. We measured the beam-hardening effect and scatter with a body 
phantom. The correction was subsequently applied empirically. We standardized the 
position (level) of the examination table, the reference calibration phantom, and the 
patients' position (we had them all lie prone), so that variabilities in CT numbers due to 
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non uniformity of the scan field were negligible. 
Comparison of our cutoff point at 140 HU (range 135-145 HU) to that of other CT 
systems is possible with conversions to equivalents of milligrams of K2HPO, per milliliter. 
In this study 135-145 HU was equivalent to 90-100 mg ofK2HP04 per milliliter. 
Because of the above-mentioned limitations in quantitative CT analysis, it is not 
possible to compare our cutoff point (140 HU) in differentiating cholesterol stones from 
mixed and pigment stones with the cutoff point (50 HU) in the study of Hickman et a! [8], 
since no data on these variabilities were given. Nevertheless, the previously reported 
inverse relation between CT attenuation numbers and cholesterol content [5,9] is con-
firmed by our in vitro and in vivo study. A discrepancy between the results of Baron et 
al[9] and ours is the good correlation we found between CT attenuation numbers and 
calcium content. We found a correlation for calcium as gocxi as for cholesterol, so we 
could not endorse their conclusions that calcium content plays a smaller role than choleste-
rol content in CT attenuation of gallstones. 
Aware of the difficulties in analysis of rimmed stones, we included these gallstones in 
our study because they form a clinically important group (28% in our study). Our data 
show that the attenuation values of such stones correlate with cholesterol and calcium 
content as well as do values of the unrimmed stones (Figs.4.4- 4.5). 
The CT patterns of our group of gallstones are similar to those in the in vivo study of 
Barakos eta! [15] and the in vitro study of Baron et at a! [9]. The percentage of undetect-
able stones in vivo (24%) is comparable to the percentage (21 %) found by Barakos eta! 
[15] and emphasizes the limitations of CT in the detecting of gallstones. Our assumption 
that these stones have attenuation numbers equal to that of surrounding bile is confirmed 
by our in vitro study, in which all gallstones had attenuation numbers below 30 HU except 
one that had a dense core and a CT number of 46 HU. Because the various types of 
gallstones showed a great range in their CT numbers, it is not sufficient to make a reliable 
prediction of gallstone composition based on CT patterns. 
In comparing the accuracy of different radiographic tests, it is important to realize that 
for predicting cholesterol stones there is a prior probability of 74%. This percentage is 
similar to the one in the study by Whiting et a! [16] (75% ). When there is a high prior 
probability, the negative predictive value is more important than the positive predictive 
value. Table 4.3 shows that in this regard CT analysis (negative predictive value in vivo, 
83.3%, in vitro, 100%) is superior to plain abdominal radiography or OCG (negative 
predictive value of 50%). 
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Figure 4.4 Diagrams show correlation between cholesterol content and CT attenuation numbers in vitro 
(r=-0.83)(top) and in vivo (r=-Q.SO)(bottom). 
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We also used receiver-operating characteristic graphs [13] to compare our results with 
those of published data (Fig.4.6). These graphs show that plain abdominal radiography (in 
this study and studies by Trotman et al [1] and Whiting et al [16]) is far inferior to CT and 
the discriminant analysis made by Dolging et al [5], because the position of these points is 
closer to the nondiscriminating diagonal. The comparison of CT analysis in vivo with the 
analysis by Dolgin et al [5] reveals similar results in sensitivity (both 95%), specificity 
(Brake! et al 77%, Dolgin et al82%), accuracy (90 vs 91 %), positive predictive value (92 
vs 93%) and negative predictive value (83 vs 88%). Nevertheless, there are important 
differences between the two studies. Dolgin et al [5] based their discriminant analysis on 
gallstone characteristics seen at OCG. OCG is less expensive than CT and is essential in 
selecting patients for nonsurgical gallstone therapy because visualization at OCG ensures 
cystic duct patency [17]. On the other hand, the method of discriminant analysis is un-
wieldy. Moreover, 15 (27%) of 56 gallstones were considered indeterminate. 
One has to take a "safety zone" 
[14] into account in CT analysis. 
In our study we based this zone on 
variations inherent in the CT 
system and on intraobserver varia-
tion. We believe a zone between 
135 and 145 HU is safe. None of 
the 50 stones we analyzed had a 
CT number in this zone. In our 
prospective test of 20 patients, one 
showed findings in this range. 
Our data show that in vivo CT 
analysis can enable prediction of 
gallstone composition more prec-
isely than plain abdominal radiog-
raphy or OCG and therefore sh-
ould play an important role in 
patient selection for nonsurgical 
treatment of gallstones. 
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CHAPTERS 
ELECTROMAGNETIC SHOCKWAVE LITHOTRIPSY OF 
GALLSTONES IN VITRO: The role of different stone charac-
teristics and treatment variables 
5.1 Abstract 
From 40 sets of five human gallstones obtained at cholecystectomy, four stones were 
subjected to either 125/250 (maximum generator output) or 250/500 (half-maximum 
generator output) electromagnetic shocl..-waves; the fifth stone was used for computed 
tomography (CT) and chemical analysis. Overall, 130 (81 %) of 160 stones fragmented, 
including 72 (45%) adequately (fragments :55 mm). After application of250 shockwaves 
(maximum generator output), the percentages overall and adequate fragmentation 
amounted to 95% and 70%, respectively. A significantly higher overall fragmentation rate 
was obtained in pure cholesterol stones (p<O.Ol), in stones with a mean CT density,; 110 
HU (p < 0.001), and in stones with a calcified rim (p < 0.05). The success of fragmentati-
on was significantly associated with stone weight and diameter (p<O.OO!), bilirubin 
content (p<0.02), and calcium content (p<0.05). A weight >500 mg and a diameter 
> 10 mm could be defined as stone characteristics being significant negative predictors of 
adequate fragmentation. High correlations between mean CT attenuation numbers (HU) 
and cholesterol (r=-0.87; p:50.001) or calcium (r=0.92; p:50.001) content were found. 
Using a cutoff point of 110 HU, pure cholesterol (~ 80% cholesterol) and noncholesterol 
stones could be discriminated by CT with an overall accuracy of 95%. 
5.2 Introduction 
From 1986 extracorporeal shockwave lithotripsy (ESWL) has been expanding as a 
nonsurgical treatment for selected patients with gallstone disease [1-3]. Biliary lithotripsy 
has been performed with electrohydraulic [4-6], electromagnetic [7,8] or piezoelectric [9, 
!O]lithotriptors. The acoustic energy output of the respective systems, however, can vary 
considerably [II]. 
SubmittOO for publication as: H. Vergunst, K. Brakel. H.G.T. Nijs, E. Matura. J. Drexler, G. Steen. F.H. 
Schroder. O.T. Terpstra. ELECTROMAGNETIC SHOCKWAVE LITHOTRIPSY OF GALLSTONES IN 
VITRO: The Role of Different Stone Characteristics and Treatment Variables. 
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This depends on the employed techniques of shockwave generation and focusing. It is thus 
conceivable that the performance of different types of ESWL devices may vary. 
In contrast to the electrohydraulic and piezoelectric systems [12-14], gallstone frag-
mentation and the role of different stone characteristics have not been systematically 
studied in vitro for electromagnetic systems. The aims of the present study were to 
evaluate the potential for gallstone lithotripsy of a recently developed electromagnetic 
shockwave source under various treatment regimens and to assess the significance of 
different stone characteristics in predicting stone fragmentation in vitro. 
5.3 Methods 
Stones 
Forty sets of five gallstones were obtained from 40 patients who underwent elective 
cholecystectomy for symptomatic gallbladder stones. By gross observation the stones 
comprising one set were comparable in morphology and size and were assumed to be of 
similar chemical composition, because they came from the same patient. The stones were 
stored at 4 oc in phosphate buffered saline (PBS), containing 50 000 lUll penicillin and 50 
000 p.g/1 streptomycin. One stone from each set was used for examination by computed 
tomography followed by chemical analysis. The remaining four stones from each set were 
used for lithotripsy experiments. 
Computed Tomography 
Computed tomography (CT) was performed with a Somatom CR (Siemens AG, Erlangen, 
Germany) at settings of 125 kV and 450 mAs. Contiguous sections of 2-mm-thickness 
were made through a cylindric plexiglas phantom containing eight chambers filled with 
physiologic saline, in which the stones were immersed individually. For each stone, mean 
CT attenuation values, expressed in Hounsfield Units (HU), were obtained by the method 
described by Brake! eta! [15]. 
At CT examination, gallstones were categorized as calcified or noncalcified according 
to Brake! eta! [15]. Calcified stones were subdivided into three groups: calcified rim (type 
I), calcified core (type II), or other pattern of calcification (type Ill). Noncalcified stones 
were subdivided into two groups: detectable (type IV), and nondetectable (type V) (iso-
attenuating with surrounding fluid). 
Chemical Analysis 
Gallstones were washed, dried superficially, and weighed to the nearest 0.1 g. After 
drying to constant weight (48 hours at 37°C), the stones were weighed again to calculate 
water content. Gallstones were ground in a mortar, and the resulting powder was used for 
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analysis of cholesterol, calcium, and bilirubin. The methods of determination of choleste-
rol, calcium, and bilirubin contents have been described elsewhere [15, 16]. 
Shockwave Device 
For shockwave lithotripsy of the gallstones the Lithostar Plus (Siemens AG, Erlangen, 
Germany) was used. This lithotriptor is based on the electromagnetic principle. At 
maximum generator output setting, the Lithostar Plus generates shockwaves with a 
maximum positive focal pressure of about 65 MPa in vitro; the focal zone (i.e., the zone 
within which more than 50% of maximum focal pressure occurs) has a length of 40 mm 
and a width of 3 mm [17]. The maximum acoustic energy output (total energy delivered 
into the focal plane by a single shockwave generated at maximum generator power) 
amounted to 70 mJ in vitro [17]. 
Lithotripsy Experiments 
The shockwave applicator was coupled by means of ultrasound coupling gel to a nonatte-
nuating elastic membrane sealing off a window of a water-filled test basin. After measure-
ment of the maximum diameter and weight, individual stones were placed in a small 
plastic net (1.5 mm meshes) suspended in the water such that the stone was exactly 
focused. The four stones of each set used for in vitro lithotripsy were subjected to different 
numbers of shoch."Waves, generated at a generator voltage setting of either 20.3 kV 
(maximum focal shockwave pressure [100%]) or 16.9 kV (half-maximum focal shock-
wave pressure [50%]): 
treatment I : 125 shock-waves, focal pressure 100% (20.3 kV); 
treatment II : 250 shockwaves, focal pressure 100% (20.3 kV); 
treatment III : 250 shock-waves, focal pressure 50% (16.9 kV); 
treatment IV : 500 shockwaves, focal pressure 50% (16.9 kV). 
Application of shockwaves was stopped before completing the intended number of 
shockwaves when the net was completely emptied. If necessary, the net was gently shaken 
during lithotripsy to allow the fragments to pass through the meshes. Fragments remaining 
in the net after maximum shock"Wave application were sieved using a metal sieve with a 
2.5 mm grid. All fragments not passing through this grid were collected and their 
diameters measured. Fragmentation was considered to be adequate when all remaining 
fragments measured ::::;; 5 mm in their largest diameter, and was considered unsatisfactory 
if fragmentation did not occur, or if at least one particle was larger than 5 mm at the end of 
the experiment. If all treatment regimens failed to fragment the stones, a total of 1500 
shockwaves generated at maximum generator output setting was administered. 
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Data Analysis 
Differences between diameter or weight between stone sets, and differences between 
chemical composition or CT density versus treatment regimen were analyzed with the 
Kruskal Wallis (multiple comparison) test, Relations between CT density and chemical 
composition were examined with Spearman's rank-correlation test, Categorized fragmen-
tation results were compared using the Chi-square test or Mann-Whitney U-test, where 
appropriate. The determination of the optimal cutoff point for CT density in predicting 
chemical composition was performed using ROC-analysis [18], 
Table 5.1 Chemical and CT analysis of 40 hwnan gallstones 
Cholesterol" Calciumb Bilirubin" 
Type of 
Gallstone No (%) (%) (%) 
All 40 93.2 ( 0.0-99.9) 0. 7 (0.0-32. 7) 0.0 (0.0-23.6) 
Pure cholesterol 30 95.4 (82.3-99.9) 0.2 (0.0- 3.9) 0.0 (0.0- 1.8) 
(280%)' 
Mixed 4 54.7 (38.0-64.9) 14.7 (3.3-19.3) 0.0 (0.0-11.4) 
(2::25%-80%t 
Pigment 6 0.0 ( 0.0-11.4) 2.1 (0.8-32.7) 10.2 (1.2-23.6) 
(225%)' 
Calcifiedr 22 84.1 ( 0.0-96.4) 1.6 (0.2-32. 7) 0.0 (0.0-23.6) 
Noncalcifiedr 18 96.2 (91.8-99.9) 0.1 (0.0- 1.2) 0.0 (0.0- 0.5) 
CT pattern I 8 91.9 (11.4-96.4) 0.8 (0.2-16.0) 0.0 (0.0-23.6) 
II 4 91.8 (85.8-94.7) 0.8 (0.6- 1.3) 0.0 (0.0- 1.3) 
III 10 19.9 ( 0.0-90.0) 3.0 (0.8-32.7) 4.0 (0.0-22.1) 
IV 16 96.2 (91.8-99.9) 0.1 (0.0- 1.2) 0.0 (0.0- 0.5) 
v 2 97.7 (95.5-99.9) 0.1 (0.0- 0.1) 0.0 (0.0- 0.0) 
NOTE: Data are given as median values with ranges in parentheses. 
a,b.d pure VS mixed, o-d pure VS pigment, "'pure VS pigment: p <0.05. 
calcified vs noncalcified: p < 0.05. 
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o.,b,<l I VS IV/V. bii VS IV. a,d II VS V. a-d III VS IV/V: p <0.05. 
percentage of cholesteroL 
r on CT scan. 
MeanCT 
densityd 
(HU) 
41 ( 7-584) 
29 ( 7-111) 
273 (117-516) 
179 ( 84-584) 
106 ( 21-584) 
21 ( 7- 41) 
79 ( 21-284) 
56 ( 49- 63) 
155 (102-584) 
22 ( 13- 41) 
8 ( 7- 8) 
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Figure 5.1 Correlation beto.veen cholesterol (top) re::.--pectively calcium (bottom) content and mean CT 
attenuation numbers (HU) in vitro of 40 gallstones. 
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5.4 Results 
The median diameter and weight of the 160 stones used for lithotripsy were 8 mm (range: 
6-!7) and 230 mg (range: 20-1840), respectively. Diameters and weights of the 40 subsets 
of stones allocated to the different treatment regimens were equal. Taken together, within 
particular sets of four stones the diameters and weights differed on average 1.0 mm 
(range: 0-6) and 72 mg (range: 0-870), respectively. 
Chemical and CT analysis of single gallstones of the 40 stone sets are given in Table 
5.1. The stones were divided into three groups, depending on cholesterol content: pure 
cholesterol (;;:80% dry cholesterol weight), mixed (;,:25% and <80%), and pigment 
stones (<25%). From the 22 stones (55%) which were calcified at CT, 8 stones (20%) 
were classified as type I, 4 stones (10%) as type II, and 10 stones (25%) as type III. From 
the 18 stones (45%) categorized as noncalcified, 16 stones (40%) were of type IV and 2 
stones (5%) of type V. Stones of type II as well as non calcified stones (types IV and V) 
were pure cholesterol stones, but cholesterol stones could also present CT patterns of type 
I and III. Pigment and mixed stones assorted to type I (n=2) and type III (n=8). 
Sensitivity 
1 o- ---::~---1:' ----+· - rc 
, I ~-~ '--- 110 ~u 
o.o 
0.0 
;_ 
0.2 0,4 0,6 
1- Specificity 
0,8 1.0 
Figure 5.2 Receiver-operating characteristic graph 
of CT attenuation cutoff numbers for classification 
of gallstones. Specificity and sensitivity of CT to 
discriminate in vitro between pure cholesterol 
(~80% cholesterol) and noncholesterol stones were 
maximized using a cutoff point of 110 HU. 
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Figure 5.1 shows a high correlation 
between mean CT attenuation numbers 
and cholesterol (r=-0.87; ps:0.001) and 
calcium (r=0.92; ps:0.001) content, 
respectively. The optimum cutoff point 
for pure cholesterol stones was defined 
by receiver-operating characteristic 
(ROC) analysis at 110 HU (Fig. 5.2), 
because at this value specificity and 
sensitivity were maximized[l8]. Using 
this cutoff point, CT discriminated bet-
ween pure cholesterol and noncholesterol 
( < 80% cholesterol) stones with a speci-
ficity of 0.90, a sensitivity of 0.97, a 
positive predictive value of 0.97, a nega-
tive predictive value of 0.90, and an 
overall accuracy of0.95. 
Irrespective of treatment regimen, 130 
(81 %) of 160 stones fragmented. Ade-
quate fragmentation (all fragments s:5 
mm) was achieved in 72 stones ( 45%). 
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Table 5.2 Results of in vitro ESWL of gallstones according to treatment regimen. 
Maximum Particle Size at End of Experiment'" 
Treatment 
Regimen 
II 
Ill 
N 
Overall 
No 
40 
40 
40 
40 
160 
Fragmentation 
32 (80%) 
38 (95%) 
28 (70%) 
32 (80%) 
130 (81 %) 
~2.5 mm >2.5 mm and :=:;;5 mm 
7 (18%) 8 (20%) 
14 (35%) 14 (35%) 
3 ( 8%) 9 (22%) 
11 (27%) 6 (15%) 
35 (22%) 37 (23%) 
NOTE: Data are given as numbers of stoni!S with po;;:;rcentages in parentheses . 
• I VS II, II VS Ill/IV: p <0.05. 
>5mm 
25 (62%) 
12 (30%) 
28 (70%) 
?' 
-0 (58%) 
88 (55%) 
Unsatisfactory results were obtained in 88 calculi (55%), including 30 stones (19%) which 
did not fragment at all. The results of the various treatment regimens according to 
different categories of remaining particle size are given in Table 5.2. 
Table5.3 Characteristics of gallstones according to results of in vitro ESVVL, irrespective of 
treatment regimen 
Maximum Particle Size at End of Experiment 
Stone Characteristics 
Diamt:ter of implant (rom) 
Weight of implant (rog) 
Cholesterol(%) 
Bilirubin (%) 
Calcium(%) 
Mean CT density (HU) 
:=:;;Smm 
(n~72) 
7.7 ± 0.2 
228 ±25 
77.6 ± 3.7 
0.8 ± 0.4 
5.1 ± 1.1 
128 ±20 
NOTE: Dataaregivenasmean ± SEMvalues. 
>5mm 
(n~88) 
9.5 ± 0.3 
470 ±46 
75.3 ± 3.9 
3.5 ± 0.7 
1.2 ± 0.2 
70 ± 8 
P Value 
< 0.00! 
< 0.001 
NS 
< 0.02 
< 0.05 
NS 
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Figure 5.3 depicts the percentage overall as well as adequate and unsatisfactory frag-
mentation. The highest percentage of (adequate) fragmentation was achieved at a gene-
rator voltage setting of 20.3 kV (focal pressure 100%) with 250 shockwaves (treatment 
IT). At this generator voltage, significant better results were obtained after application of 
250 (treatment II) versus 125 (treatment !) shockwaves (p < 0.05). At 16.9 kV (focal 
pressure 50%), doubling the number of shockwaves from 250 (treatment III) to 500 
(treatment IV) also improved the results albeit not significantly. Halving of the focal 
pressure was not fully compensated for by administration of twice as many shockwaves as 
evidenced by comparing the results of treatment I and IV, for instance; the number of 
shockwaves must be increased four-fold to achieve comparable results. 
% of Stones 
100 
[ IIIII: Fragmentation CJ >5 mm C <•5 mm I 
80 
0 
II lll IV 
Treatment 
Figure5.3 Percentage of total. ad~uate (fragments ~5 mm). and unsatisfactory (fragments >5 mm) in 
vitro fragmentation of 40 sets of gallscones for 4 different treatment n::gimens (I: 125 shock-wa-
ves. 100% focal pressure; II: 250 shockwaves, 100% focal pressure; III: 250 shocJ:..-waves, 50% 
focal pressure; IV: 500 shock-waves. 50% focal pressure). 
Table 5.3 shows different stone characteristics according to results of fragmentation, 
irrespective of treatment regimen. Only the stone diameter and weight (p < 0.001) as well 
as the bilirubin content (p<0.02) and calcium content (p<0.05) were significantly 
associated with adequate fragmentation. Independent of treatment regimen and without 
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regard to fragmentation outcome, a significantly higher percentage of pure cholesterol 
stones (p < 0.01). stones with a mean CT density ,; I 10 HU (p < 0.001). and stones with a 
calcified rim (p < 0.05) fragmented as shown in Table 5.4. 
Table 5.4 Results of in vitro ESWL according to different stone categories 
Maximum Particle Size 
at End of Experiment* 
:S5mm >5m.m 
Stone Categories No Fragmentation ° (n~72) (n~S8) P Value 
Weight: 
:=:;: SOOmg 126 105 (83%) 67 (53%) 59 (47%) NS 
> 500mg 34 25 (74%) 5 (15%) 29 (85%) < 0.001 
Diameter: 
~ lOmm 129 107 (83%) 66 (51%) 63 (49%) NS 
> IOmm 31 23 (74%) 6 (19%) 25 (81 %) < 0.001 
Cholesterol: 
~ 80% 120 104 (87%) 53 (44%) 67 (56%) NS 
< 80% 40 25 (65%) 19 (48%) 21 (52%) NS 
Mean CT density: 
,; llOHU 120 105 (88%) 53 {44%) 67 (56%) NS 
> llOHU 40 25 (63%) 19 (48%) 21 (52%) NS 
Calcified on CT: 
+ 88 68 (77%) 37 (42%) 51 (58%) NS 
72 62 (86%) 35 (49%) 37 (51%) NS 
CTpattem: 
32 29 {91 %) 15 (47%) 17 (53%) NS 
II + Ill 56 39 (70%) 22 (39%) 34 (61 %) NS 
II 16 14 (88%) 5 (31 %) 11 (69%) NS 
I +III 72 54 (75%) 32 (44%) 40 (56%) NS 
NOTE, Data are given as numbers of stones with percentages in parentheses. 
cholesterol ~SO% vs < 80%. mean CT density :=:;; 110 HU vs > 110 HU. 
CT pat~m I vs II + III: p < 0.05. 
¢ weight ::::;500 mg vs >500 mg. diameter :S; 10 mm vs > 10 mm: p <0.05. 
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Except for a stone weight > 500 mg and a diameter > 10 mm, other stone characteristics 
which were significant negative predictors of adequate fragmentation, however, could not 
be identified. 
Thirty-two stones from 14 different stone sets did not fragment, but in only 3 sets 
fragmentation failed with treatment II. In 2 sets (pigment stones, CT type III) all treatment 
regimens failed to fragment the stones. In these cases, application of 1500 shockwaves 
(focal pressure 100%) was still insufficient in the one, whereas this resulted in adequate 
fragmentation in the other case. 
5.5 Discussion 
In this study a single stone of each set from one patient was used for chemical and CT 
analysis because we assumed that this stone would be representative. This is justified by the 
observation that the chemical composition of multiple stones obtained from the same 
patient varied with only 2.5% [19]. 
The utility of computed tomography for predicting gallstone composition is an unsettled 
issue yet [20,21]ln the present study, however, pure cholesterol stones were reliably ident-
ified (overall accuracy 95%) by mean CT attenuation numbers using a cutoff point of 110 
HU. Brake! et al. achieved a similar overall accuracy using a cutoff point for pure 
cholesterol stones of 140 HU [15] Because HU values are device-dependent, the cutoff 
points for different CT systems cannot be compared unless a reference calibration phantom 
is used by which CT numbers can be converted to equivalent values of milligrams of 
K2HP04 per ml [15]. We found an inverse relation between CT attenuation numbers and 
cholesterol content, confirming earlier in vitro as well as in vivo observations [13,15,22-
24]. Unlike Baronet al., but corroborating other studies, we also found a good correlation 
between CT attenuation and calcium content [13,15,24,25]. 
The various CT patterns of the gallstones in this study were similar to those described 
previously [13,15,22,25,26] Stones which were noncalcified by CT appearance (type IV 
and V) and stones with a calcified core (type II) invariably were pure cholesterol stones, in 
accordance with the findings of Baron et al [22] The other CT patterns (type I and III), 
however, may correspond with cholesterol as well as with mixed and pigment stones. 
Therefore, qualitative CT analysis of gallstones based on different CT patterns provides 
some insight into the chemical composition, but does not allow a definite distinction in 
stones with a high cholesterol content and those with a low cholesterol content. 
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Evaluating our results, it should be considered that the use of a net to contain the 
gallstones and the encouragement of the passage of the fragments through the mesh during 
in vitro lithotripsy is not fully representative of the situation in vivo. During in vivo 
lithotripsy fragments are known to impede both the visualization and possibly the transmis-
sion of the shockwaves. Therefore clearance of these fragments during in vitro analysis 
probably artificially improves the results obtained. 
We defined the endpoints of fragmentation as adequate (all remaining particles :55 
mm) versus unsatisfactory (no fragmentation or at least one residual particle > 5 mm). The 
rationale for this stratification is based on the observation that spontaneous passage of 
fragments up to 5 mm through the cystic duct and the papilla of Vater appears to be 
possible and rarely causes clinical and/or biochemical symptoms [28]. Furthermore, post-
ESWL oral dissolution therapy resulted in a significantly higher stone-free rate when all 
residual fragments measured :55 mm [5] 
Comparable in vitro gallstone fragmentation studies have been performed using both 
electrohydraulic [12, 13] and piezoelectric shoch.'Wave devices [14] Schachler et a!. 
achieved adequate fragmentation (:55 mm) in 42 of 51 solitary stones (82%) after 
application of at most 1500 shockwaves [12] In the study of Barh.'Un eta!. a mean number of 
more than 2000 shockwaves was administered to achieve fragmentation in 68 of 85 stones 
(80%), adequate fragmentation (:55 mm) occutring in only 27 stones (32%) [13] Ell eta!. 
applied a maximum of 4000 shockwaves which effected fragmentation of all stones 
(n=l77), 86% of which fragmented "appropriately" (:54 mm) [14]. In the present study 
overall fragmentation was attained in 81% and adequate fragmentation in 45% of the 
stones. However, it must be emphasized that in our study 4 different treatment regimens 
were followed, applying considerably lower numbers of shockwaves than in the aforemen-
tioned studies. We are aware that the number of shockwaves used is not representative for 
the number of shoch.'Waves normally used in the clinical setting. The reason that we have 
decided to use such a small number of shockwaves is that otherwise it might have been 
impossible to establish any relationship between energy setting and the number of shock-
waves. Considering only the results of treatment II (highest effectiveness), 38 out of 40 
stones (95%) fragmented, including 28 (70%) adequately. It is thus conceivable that these 
results would have been even better if a higher number of shockwaves had been applied. 
There are several possible explanations for the varying results obtained in the various in 
vitro experiments. Firstly, the employed shockwave devices differ in acoustic energy 
output which is directly related to the effectiveness [11]. As shown in this experiment, 
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lower energy settings (resulting in lower focal shockwave pressures) can be compensated 
for by increasing numbers of shock'Waves, but the relation between the energy and the 
number of shockwaves required for stone fragmentation seems to be not linear but 
exponential [27]. Secondly, the respective stone populations are not fully comparable with 
respect to stone size. Particularly in the present study, the median stone diameter was 
relatively small, probably because these stones were collected from patients with multiple 
stones. This is of interest because stone size is shown to be an important determinant of the 
outcome of fragmentation, which became also apparent from this study [4,5,10,12-14]. 
Thirdly, it cannot be excluded that the treatment geometries in the various fragmentation 
experiments have been different [29]. Finally, the differing numbers of shockwaves 
applied in the various studies might have been of importance in determining the results. 
Confirming previous observations [12-14], we did not find any relationship between 
chemical composition, mean CT density, or CT pattern and adequate fragmentation except 
that bilirubin and calcium content may play a certain (minor) role. Nevertheless, some 
stone categories (pure cholesterol stones, stones with aCT number,; 110 HU,and stones 
with a calcified rim) seem to fragment easier than other ones (Table 5.4). 
Barkun et a!. established a stone diameter ,; 15 mm, the presence of an angular stone 
shape and a stone density distribution index ~ 60 HU as strong determinants of satisfactory 
fragmentation (,;5 mm) [13]. In our study, a stone weight >500 mg and a stone diameter 
> 10 mm were identified as categorical variables determining the result of fragmentation in 
a negative way. 
In conclusion, the fragmentation efficacy of electromagnetic ESWL is mainly deter-
mined by the energy output of the lithotriptor and by the size, but not by chemical com-
position and CT characteristics of the stones. Quantitative CT analysis can provide reliable 
prediction of gallstone composition and therefore may play an important role in the 
selection of patients where primary or adjuvant chemolitholysis is considered as nonsur-
gical treatment. The present data warrant further clinical validation. 
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CHAPTER6 
THE VALUE OF ULTRASOUND IN THE FOLLOW-UP OF 
PATIENTS TREATED WITH BILIARY LITHOTRIPSY: 
Implications for Monitoring Patients after Nonsurgical Therapy 
of Gallbladder Stones 
6.1 Abstract 
Both ultrasound (US) and oral cholecystography (OCG) can be used for monitoring 
patients after nonsurgical therapy of gallbladder stones. US is most preferred. In order to 
establish the value of US in the follow-up of patients treated with extracorporeal 
shock-wave lithotripsy (ESWL), the results of 484 US examinations from 87 patients were 
analyzed and related to the results of ESWL. Reliability of US to assess efficacy was 
investigated by comparing consecutive US examinations. Unreliable US results were 
found in 36 patients (41 %); in 7 patients US failed to demonstrate fragments; in 19 
patients there was an inaccurate measurement of the largest fragment size and 13 patients 
had nondiagnostic US examinations. In 9 patients (10%) unreliable US findings contrib-
uted to delayed retreatment with ESWL. To avoid errors in treatment regimen, verifica-
tion of US findings is advised in case of demonstrating no fragments or fragments < 5 
rom. 
In 22 patients (25%), US findings appeared indicative for hampered stone migration: a 
contracted gallbladder in 15 patients, a common bile duct > 7 mm in 6 patients, hydrops 
and signs of pancreatitis in one patient each. Only 2 of these 22 patients (9.1 %) became 
free of stones compared to 32 of the remaining 65 patients (49.3%)) (p < 0.01) even 
though both groups had similar initial stone characteristics and similar time of follow-up. 
Therefore US findings such as a contracted gallbladder or a CBD > 7 mm indicate poor 
efficacy of ESWL. 
Submitted for publication as: Ko~n Brakd, M.D .. Rene den Toom. M.D., Johan S. Lam~ris. M.D .. Huub 
G.T. Nijs, M.D .. Rene L. van der Hul, M.D .. Peter W. Plaisier. M.D., Onno T. Terpstra. M.D .. Henry E. 
Schutte, M.D .. THE VALUE OF ULTRASOUND IN THE FOLLOW-UP OF PATIENTS TREATED 
WITH BILIARY LITHOTRIPSY: Implications for Monitoring Patients after Nonsurgical Therapy of 
Gallbladder Stones. 
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6.2 Introduction 
In contrast with cholecystectomy. nonsurgical gallstone therapies affects gallstones only. 
Meticulous follow-up of patients treated in this way is necessary in order to assess stone 
fragmentation and/or clearance and possible recurrence. As a result of this follow-up, 
clinicians have to decide whether to cease or continue therapy or to retreat patients. For 
follow-up, both ultrasound (US) and oral cholecystography (OCG) can be used. US is 
preferred because it is harmless, cheap and highly sensitive in the detection of gallstones 
or its fragments. Nevertheless US has shown to be of limited value to assess precisely the 
number and size of gallstones [1-4]. Furthermore, in case of fragmentation treatments 
such as extracorporeal shockwave lithotripsy (ESWL), fragments may clump together and 
this also may lead to less accuracy [3,5]. 
Follow-up is also necessary to be informed about possible complications of nonsurgical 
gallstone therapy. These complications are on the one hand related to the migration of 
stone fragments from the gallbladder to the duodenum and on the other hand to the therapy 
itself, for instance energy trauma in case of ESWL. US should be able to provide infor-
mation concerning possible complications. 
To evaluate the value of US in the follow-up of patients treated with ESWL, the 
following questions were addressed: 
1. What is the reliability of US in the assessment of stone fragmentation and/or clearance 
following treatment with ESWL? 
2. In which way, decisions concerning the treatment regimen are affected by unreliable 
US results? 
3. Can US indicate hampered migration of stone fragments and therefore indicate poor 
efficacy of ESWL? 
4. Wbat complications caused by shock-wave lithotripsy itself are detected with US? 
For these purposes we analyzed retrospectively in 87 patients the post-ESWL US findings 
and related them to the results and complications of ESWL. 
6.3 Materials and Methods 
From April 1988 to July 1991, 87 patients with symptomatic gallbladder stones (27 males, 
60 females, mean age 48.1 years, ± 12.1 SD; range 28-81) underwent 203 treatments 
with an electromagnetic lithotriptor. (Lithostar" and Lithostar plus®, Siemens AG, 
Erlangen, Germany) as part of an ongoing trial [6]. Only patients with follow-up in our 
hospital were included in this study. All patients received a combination of urso- and 
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cheno-desoxycholic acid 7-8 mg/kg bodyweight in one dose in the evening) as an adjuvant 
treatment. 
The in- and exclusion criteria were comparable with other ongoing trials for lithotripsy 
with one major difference that patients were included with up to 10 stones and without 
being limited by the size of the stones. Forty-five patients (52%) had a solitary stone, 27 
(31 %) had 2 or 3 stones and 15 (17%) had 4-10 stones prior to ESWL. The mean diameter 
of the largest stone was 17.4 mm ± 7.2 SD (range 5-35). 
US examinations were performed 7-10 days after lithotripsy. Retreatment by lithotrip-
sy was carried out if fragments of 5 mm or larger were present. After successful treatment 
(fragments reduced to < 5 mm) US was repeated every 3 months. When US revealed 
complete clearance of the stones, the adjuvant therapy with oral bile acids was continued 
for 3 months and subsequently stopped if the next verifying US again showed the absence 
of fragments in the gallbladder. 
US was performed by several radiologists, not associated with the lithotripsy trial. It 
was performed in the fasting state on real time equipment with 3.5 MHz or 5.0 MHz 
curved array or sector transducers. Sections of the gallbladder were obtained in different 
planes with patients in supine, left posterior oblique and erect positions. The following US 
findings were recorded on standardized forms: 
L The size and shape of the gallbladder, i.e. normal, contracted or hydropic. A gall-
bladder was considered contracted when the lumen of the gall bladder contained only 
calculi without normal surrounding bile. Hydrops was assumed when the transverse 
diameter of the gallbladder measured more than 4.5 em [7]. 
2. The number and size of gallstones or fragments. Only stones with a diameter of 3 mm 
or larger were counted. Stones or fragments smaller than 3 mm were considered to be 
grit (sand). The number of stones was categorized as l, 2, 3, 4, 5, 6-10 or more than 
I 0 stones. Only the size of the largest stone or fragment was recorded. 
3. Other US findings concerning the gallbladder and bile ducts such as: a generally 
thickened gallbladder wall, impaction of stones or fragments in the cystic duct or gall-
bladder neck; sludge, a diameter of more than 7 mm of the common bile duct, 
dilatation of intrahepatic bile ducts. 
4. Abnormalities appearing in the liver parenchyma, the pancreas and the right kidney 
were also recorded. 
US was considered unreliable to evaluate the number and size of gallstones when: 
1. An US examination in which stones or residual fragments could not be demonstrated, 
was followed within 3 months by US in which stones or fragments were demonstrated, 
obviously not due to stone recurrence. 
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2. Two consecutive US examinations within 3 months, in which the last examination 
revealed a largest fragment diameter to be more than 3 larger than was measured in the 
former examination. 
3. An examination was recorded as nondiagnostic concerning the number and size of 
gallstones or fragments, e.g. in case of a contracted gallbladder or aggregation of stone 
fragments. 
The following US findings were recorded as indicative for hampered migration of stone 
fragments: a contracted gallbladder, hydrops of the gallbladder, diameter of common bile 
duct larger than 7 mm and signs of pancreatitis, such as enlargement and echopoor aspect 
of the pancreas or fluid collections around the pancreas. 
Data analysis 
Results are given as mean (range) or mean ± SD, as indicated. Continuous data were 
compared with the Mann-Whitney U-test. Proportions were compared using a standard 
test assuming two binominal distributions or with the Chi-square test. 
Table 6.1 US examinations with unreliable results concerning the stone f~amentation and/or 
clearance in 87 patients 
incorrect stone free 
inaccurate measurement 
nondiagnostic because of: 
-contracted gallbladder 
- aggregation of stone fragments 
numb<;!rof 
patients 
7 
19 
9 
4 
36"(41%) 
contributed to delay in, 
retrcatment with ESWL 
8 
9 (10%) 
~ three patients had a combination of two examinations with unreliable results. 
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6.4 Results 
Eighty-seven patients underwent 464 post-ESWL US examinations. US examinations in 36 
patients ( 41%) were considered unreliable concerning the assessment of stone fragmenta-
tion and/or clearance (Table 6.1). In 19 cases this was due to inaccurate measurements. In 
7 patients US incorrectly did not demonstrate stones or fragments. In 9 patients an 
unreliable US examination contributed to delay in retreatment with ESWL of at least 3 
months. 
Table 6.2 Ultrasound findings indicative for hampered migration of stone fra,_oments 
FOLLOW-UP 
US fmdings patients stone fr~ transient cholecystectomy 
contracted gallbladder 15 7 4 
hydrops of the gallbladder 
common bile duct > 7 m.m 6 4 
pancreatitis 
22. 2 11 7 
· one patient had a combination of US findings. 
The US findings of 22 patients (25%) indicative for hampered migration of stone 
fragments are listed in Table 6.2. The most frequent fmdings were a contracted gall-
bladder in 15 patients (17%) and a common bile duct larger than 7 mm in 6 patients (7%). 
In II patients the US findings returned to normal. Seven patients underwent cholecystec-
tomy either because ESWL was considered inadequate or because of complications of 
ESWL. 
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Among the patients a statistically significant difference in the percentage who were free 
of stones (p < 0.01) was found between the group of 22 patients with US findings 
indicative for hampered stone migration (9 .1%) and the remaining 65 patients without 
these findings (49.3%). The two groups of patients did not significantly differ in baseline 
stone characteristics or time of follow-up (fable 6.3). 
Table 6.3 Comparison of stone characteristics, results and complications in 2 groups of patients with 
and without US findings indicative for hampered stone migration 
baseline stone characteristics: 
·solitary stone 
·2-3 stones 
· > 3 stones 
·diameter largest stone (mm) 
mean time follow-up (months) 
therapeutic results: 
·no fragmentation 
· < 50% decrease in diameter 
of the largest stone 
· > 50% decrease in diamder 
of the largest stone 
·grit (sand) 
·free of stones 
complications: 
·colics 
cholecystectomy 
~ percentages in parentheses 
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group of22 patients with 
US findings indicative for 
hampered stone migration 
10 (45.5)" 
8 (36.3) 
4 (18.2) 
20.8 ± 7.8 
10.5 ± 6.7 
(range 1-21) 
2 (9.1) 
6 (27.2) 
9 (40.9) 
3 (13.6) 
2 (9.1) 
9 (40.9) 
7 (31.8) 
group of65 patients without 
US findings indicative for 
hampered stone migration 
35 (53.9) } 19 (29.3) 11 {16.9) 
16.2 ± 6.7 
12.8 ± 8.5 
(range 1-36) 
2 (3.1) 
11 {16.9) 
11 (16.9) 
9 (13.8) 
32 (49.3) 
22 (33.8) 
6 (9.2) 
Pvalue 
n.s. 
n.s. 
n.s. 
< 0.01 
n.s. 
< 0.01 
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In two patients, the US examination one week after ESWL, showed an echo poor focal 
lesion of ± 2 em of the liver adjacent to the gallbladder, which was considered to be a 
hematoma. There were no clinical or laboratory signs of damage to the liver in these 
patients and the lesions disappeared spontaneously and could not be demonstrated on the 
next follow-up US examination. 
6.5 Discussion 
This study demonstrate some limitations of US to assess stone fragmentation and/or 
clearance in patients treated with ESWL. Limitations of US in assessing the number and 
size of gallstones and fragments have been ascribed to patient, technical and observer 
related factors [8]. ESWL itself also induces additional diagnostic problems [5]. In this 
study 13 patients (15%) had nondiagnostic US examinations concerning the assessment of 
efficacy because of side effects that were induced by ESWL. In 9 cases this was caused by 
a contracted gallbladder. In 4 patients reliable interpretation of the US examination was 
not possible due to clumping of fragments. Although we did not use "rollover maneuvres" 
to prevent clumping as advised by Khouri et al [5], patients were examined in different 
positions including the erect position. Because the phenomenon of clumping is most 
evident on US within 24 hours ofESWL, we started US evaluation 7-10 days after ESWL. 
Therefore clumping plays a minor role in the problems associated with imaging after 
ESWL. 
Interpretation of post-ESWL US examinations may be influenced by the so-called 
comet-tail artifact [9]. However this artifact is only observed on US within a few days 
after ESWL and was not observed in this study, probably because we started evaluation 
after 7-10 days. 
In evaluating the efficacy of ESWL two major questions should be addressed. Firstly to 
determine the necessity for retreatment with ESWL. In most protocols patients are eligible 
for retreatment if residual stone fragments are larger than 5 mm. 
Retreatment with ESWL was delayed in 9 patients (10%), because the fragment size 
was underestimated in 8 patients and US was nondiagnostic in 1 patient. These findings 
support the results of a study by Baumgartner et al [10] in which oral cholecystography 
(OCG) proved more reliable than US in deciding patient eligibility for repeated ESWL. 
They therefore proposed that OCG should be an integral part of follow-up evaluation in 
ESWL. 
In our opinion the use of OCG is only beneficial when the first US examination in 
follow-up evaluation reveals fragments smaller than 5 mm. In this situation a verification 
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OCG or US within a short period of time should be performed in order to decide whether 
or not to cease ESWL. 
The second question concerning efficacy is the assessment of complete disappearance 
of stones and/or grit (sand) to cease further adjuvant therapy. In our protocol, patients free 
of stones continue adjuvant oral bile acid medication for three months, after which US is 
performed to verify the absence of stones. The necessity of this verification is proven by 
the outcome of this study in which the verification US examinations revealed grit or even 
fragments in 7 patients (8%), in spite of the former US examination in which no stones or 
fragments could be demonstrated. Because the verification US was performed within 3 
months during oral medication of bile acids, recurrence of stone formation is unlikely[ll]. 
The reliability of US to assess stone fragmentation and/or clearance was investigated in 
this study by comparing consecutive US examinations. Of course, this method have limita-
tions because a gold standard is not available. These patients normally do not undergo 
cholecystectomy. 
This study shows that US may provide important information concerning the ultimate 
stone clearance after ESWL. The 22 patients with US findings indicative for hampered 
stone migration had significantly lesser percentages of complete stone clearance compared 
with the group of patients without these US findings. The most frequent US finding in 
these 22 patients was a contracted gallbladder in 15 patients. A contracted gallbladder as 
assessed with US is highly specific in predicting non-visualization of the gallbladder on 
oral cholecystography [12]. Gallbladder visualization on OCG is required for oral treat-
ment with bile acids because this ensures both cystic duct patency and concentration 
capability of the gallbladder. The utility of continuing oral medication of bile acids in 
patients with a contracted gallbladder is therefore very doubtful. 
In this study a contracted gallbladder was found in 15 of 87 patients (17% ). This is 
similar to the frequency of non-visualization of the gallbladder on post-ESWL OCG in 5 of 
39 patients (13%) as reported by Baumgartner et al [10], however more than Sackmann et 
a! [13] who reported a contracted gallbladder on US and a non-visualized gallbladder on 
OCG in only 5 of 175 patients (3%). Maybe this is due to the extended inclusion criteria 
for stone characteristics in our protocol [6]. 
Complications of ESWL as a result of shockwave therapy, i.e. energy trauma, are 
mostly mild and limited to transient microscopic hematuria and skin petechia. More 
serious complications that could be assessed with US are extremely rare and limited to one 
case report [14]. Our findings of two cases with suspected liver hematoma are hard to 
prove, because of the absence of clinical and laboratory signs in these patients, although 
the temporary nature of these findings is circumstantial evidence for trauma. 
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We conclude that US has some limitations in assessing the efficacy of ESWL. These 
limitations can influence clinical management in two ways: 
I. Overestimation of efficacy by incorrectly demonstrating no fragments. Therefore a 
verification US is advised and claims regarding success without a verification US 
should be regarded with caution. 
2. Delay in retreatment with ESWL by underestimation of the fragment size. Therefore a 
verification OCG or US is advised if US reveals fragments smaller than 5 mm. 
It is expected that these limitations also affects the follow-up of other nonsurgical 
treatment of gallbladder stones such as oral and local contact dissolution therapies. 
It is furthermore concluded that US findings indicative for hampered stone migration 
indicate poor efficacy of ESWL. In patients with a contracted gallbladder continuing oral 
medication with bile acids is doubtful. 
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PERCUTANEOUS CHOLECYSTOSTOMY FOR TREAT-
MENT OF GALLBLADDER STONES 
7.1 Introduction 
Percutaneous cholecystostomy was initially introduced to decompress the gallbladder 
and/or bile ducts in case of acute cholecystitis and (malignant) obstruction of the common 
bile duct [1-7]. The percutaneous approach has proven to be a viable alternative for 
surgical cholecystostomy in severely ill patients with high-risk for general anesthesia. 
With increasing experience, percutaneous cholecystostomy was also used as a diagnostic 
procedure to assess biliary obstruction and as a method to enable percutaneous treatment 
of gallstones [8-13]. This chapter presents an outline of the technical aspects of percutane-
ous cholecystostomy and discusses the most important percutaneous techniques for the 
treatment of gallbladder stones. 
7.2 Technical aspects of percutaneous cholecystostomy 
7.2.1 Access route to the gallbladder 
To obtain access to the gallbladder, a transhepatic and a subhepatic route are available. 
Most investigators prefer the transhepatic route to the upper one third of the gallbladder 
where it is attached to the liver surface ("bare area"). Theoretically, risk of bile leakage 
into the peritoneal cavity is reduced using this approach [ 4,5]. However this advantage is 
still unproven, as the reported frequency of bile leakage for the different access routes is 
very low (about I%) [12]. Catheters used for the transhepatic approach have to be limited 
in size because of the risk of damage to liver tissue. Another potential drawback of the 
transhepatic route is that it may be difficult or even impossible to avoid the pleural space. 
A transpleural puncture can cause additional pain and creates an artificial connection 
between the peritoneal and pleural cavities. 
The second approach is the direct transperitoneal subhepatic puncture to the fundus of 
the gallbladder. This route avoids the pleural space and avoids unnecessary damage to the 
liver. Ultrasonography is generally adequate to ensure a safe subhepatic route, although it 
is sometimes difficult to avoid the colon. For this reason and because of large variations in 
right upper quadrant anatomy, computed tomography is advocated by some as a better 
method to assess a safe access route [14,15]. A potential risk of the direct subhepatic route 
is that contact with the gallbladder can be lost during dilatation of the tract. The develop-
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ment of a removable anchor device [10] that fixes the fundus of the gallbladder to the 
anterior abdominal wall seems to have solved this problem. This creates a safe and short 
track to the gallbladder which allows introduction of large catheters and stone removal 
devices. 
7 .2.2 Puncture techniques 
The initial puncture of the gallbladder is usually performed under ultrasound guidance. 
For subsequent catheter placement fluoroscopy is preferable, although a bedside procedure 
using only ultrasound guidance is feasible [4]. In case of doubt concerning a safe puncture 
route, computed tomography is indicated. There are several methods described for 
catheter placement and the "best" method is dependent on personal experience and 
preference. Many investigators prefer the Seldinger technique. A thin needle (22-gauge) is 
used for initial puncture of the gallbladder after which a guide-wire (0.018 inch) is 
inserted. Over the guide-wire a combination of an 18-gauge needle and a 6-F catheter is 
introduced. After dilatation of the track the final catheter is installed. lf unsuccessful, the 
initial puncture with the thin needle can safely be repeated, which is an advantage over 
other methods. Because this method uses exchanges over a guide-wire, the risk of leakage 
of a small amount of bile is present. Another drawback of the Seldinger method is that 
contact with the gallbladder during exchange and dilatation can be lost, with subsequent 
failure of the procedure. Therefore others advocate the Trocard method [6]. This method 
is a single-step procedure in which the puncture is performed with a thick needle with a 
preloaded catheter. After introduction of the needle into the gallbladder, the catheter is 
pushed off; this method avoids bile leakage and catheter positioning problems. The initial 
puncture, however, cannot be repeated without serious risks of liver damage or bile 
leakage. 
7 .2.3 Complications of percutaneous cholecystostomy 
Recently, Teplick and colleagues [12] reviewed the results of successful percutaneous 
cholecystostomy in 252 patients that were reported in literature, including their own 
patients. The indications for percutaneous cholecystostomy were acute cholecystitis and 
desobstruction of bile ducts in, mostly, severely ill patients. The complication rate was 
8%. The most serious complications were peritonitis caused by bile leakage (4 cases, one 
of which was fatal [5]), hemobilia (5 cases) and severe vasovagal reactions (4 cases, one of 
which led to a nonfatal cardiac arrest [16]). 
One cause of bile leakage is early removal or dislodgement of the cholecystostomy 
catheter. Therefore the catheter has to remain in situ for at least 7-10 days, the time in 
82 
Percutaneous treatment of gallbladder stones 
which a tract develops. If early removal is desired gelfoam, or other material, to plug the 
puncture site should be used. The cause of vasovagal reactions is unlmown but the severe 
reactions mentioned above were only seen in patients with an underlying cardiac disease. 
Prophylactic use of atropine and minimizing manipulations with guide-wires and catheters 
in the gallbladder are advocated to prevent these vasovagal reactions. 
7 .2.4 Patient care around the procedure 
Commitment to patient care around interventional procedures is essential for the radiolo-
gist [17]. Before the procedure is performed, screening for bleeding disorders is neces-
sary. Solid food is withheld for 8-12 hours prior to the procedure. Patients should receive 
prophylactic antibiotics in case of infectious disease of the gallbladder or bile ducts. 
Pain and anxiety are treated with local anesthetics (lidocaine) and an i.v. combination of 
an opium derivate and a benzodiazepine (common practise is a combination of fentanyl 
and midazolam). Atropine is administered to prevent vasovagal reactions. During the 
procedure, monitoring the patient by means of oxymetry, electrocardiography and 
continuous bloodpressure measurements, is strongly advised. 
7.3 Percutaneous contact dissolution of gallbladder stones by methyl tert-butyl ether 
7.3.1 Dissolution solvent 
At present methyl ten-butyl ether (MTBE) is the only solvent used for percutaneous 
contact dissolution of gallbladder stones. MTBE is an alkyl ether similar to diethyl 
(anesthetic) ether which was Jmown to dissolve cholesterol gallstones rapidly. Diethyl 
ether was used to dissolve retained bile duct stones until the 1950s, but it produced serious 
side effects owing to the volatilization of ether at body temperature [18]. The boiling point 
ofMTBE is 55.2°C, it remains liquid at body temperature and is therefore less volatile. 
In the past decades several cholesterol solvents has been used to dissolve cholesterol 
bile duct stones. such as mono-octanion [19,20], limolene [21] and mixtures of limo1ene 
and mono-octanion [18]. In vitro tests have shown that MTBE dissolves cholesterol stones 
50-200 times faster than mono-octanion [22-23] and 10 times faster than limolene or a 
mixture of limolene and mono-octanion [23]. Thus MTBE is the most potent cholesterol 
solvent now available. MTBE is also able to completely dissolve stones with only 40% 
cholesterol [22]. Vergunst and colleagues [23] reported partial dissolution of pigment 
stones in vitro by MTBE. Encouraging clinical results are reported with 1% EDT A (a 
calcium chelating agent) solutions in combination with bile acids and mono-octanion to 
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dissolve brown pigment stones m the bile ducts [24]. However, it seems that black 
pigment stones in the gallbladder are practically insoluble [18]. Clinically successful 
dissolution of calcified pigment stones in the gallbladder is limited to one case report [25]. 
7.3.2 Patient selection for MTBE tberapy 
Selection of patients for MTBE therapy is based on two major issues: (1) the composition 
of gallstones and (2) the patency of the cystic duct. Only patients with cholesterol stones, 
irrespective of the number and size, are eligible. The classic radiographic criterion for 
assessment of cholesterol stones has been radiolucency on plain abdominal radiography or 
oral cholecystography (OCG). The predictive value of this feature is low [26,27]. Additio-
nal computed tomography is advised to predict gallstone composition more precisely 
[27,31] and to ensure the absence of calcifications in gallstones [28-30]. 
Protocols in the two largest studies of MTBE therapy [29 ,30] include only patients 
with a patent cystic duct as assessed by visualization of the gallbladder on OCG. This issue 
is disputed by others [32,33]. Cystic duct patency is desirable to enable the migration of 
residual debris from the gallbladder to the intestine. However, patients have been treated 
successfully with MTBE in the presence of an occluded cystic duct [34]. These patients 
suffered from acute cholecystitis and underwent percutaneous cholecystostomy to 
decompress the gallbladder. After regression of the signs of inflammation subsequent 
dissolution of the gallstones by MTBE was achieved. 
7.3.3 Method of solvent delivery 
MTBE has some qualities that need special care and attention. MTBE is a foul-smelling, 
volatile, inflammable liquid that is anesthetic at high concentrations. Therefore MTBE 
therapy should be carried out in a well-ventilated room, preferably with external exhaust 
ventilation [29]. In addition to its superb properties to dissolve cholesterol, MTBE also 
macerates and destroys plastics and synthetics [35]. Therefore catheters must be made of 
teflon, polyethylene or polyurethane; only glass syringes and metal stopcocks can be used. 
Usually the percutaneous transhepatic approach is used for insertion of a catheter into 
the gallbladder. The technique was discussed in section 7.2.2. Some authors advocate an 
endoscopic retrograde cannulation of the gallbladder to instill MTBE [36,37]. Technical 
difficulties to pass the spiral-shaped Heister valves in the cystic duct and the inability to 
manipulate the catheter when introduced in the gallbladder, impedes extended clinical 
application of this method. 
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Several factors will influence the dissolution rate of cholesterol stones by MTBE. 
These factors include [34]: 
1 the viscosity of MTBE, which is very low and therefore contributes to its excellent 
dissolution properties, 
2 the contact time of the solvent with the stones 
3 stirring or agitation of the solvent. (this is necessary because MTBE floats on bile and 
gallstones sink in bile). 
The ideal method to dissolve gallstones with MTBE will be achieved with a catheter 
position surrounding the gallstones and with continuous infusion and aspiration of MTBE. 
Overflow of MTBE from the gallbladder to the bile ducts can cause serious side effects 
such as ulcerative duodenitis and hemolysis. The "overflow volume" can be assessed by 
injecting a contrast agent in the gallbladder under fluoroscopic control before the therapy 
is started. This should be repeated periodically during the therapy because the volume of 
the gallbladder can change in time. Until now, treatment in most patients has been by 
manual instillation and aspiration of small volumes (2 - 15 ml) of MTBE 4 - 6 times a 
minute [29 ,30]. As this method is tedious and labour intensive, automatic solvent delivery 
systems have been developed. Zakko designed a pressure controlled pump [38,39] (Lithox 
Systems, Salem, Mass. USA) that regulates instillation and aspiration volumes of the 
solvent by a pressure monitor. The pump automatically responds to changes in gallbladder 
volume, so changes in the "overflow volume" are corrected. The Mayo group designed a 
volume-controlled pump [40] (Baxter Health Care, Irvine, Calif. USA) that fixes instillati-
on and aspiration volumes of the solvent, which is set after assessment of the "overflow 
volume". Preliminary results in patients showed that efficacy was identical to the manual 
syringe method but the working time of an operator was reduced with 70% [41]. It is 
expected that both pumps will soon be commercially available. 
7 .3.4 Results of contact dissolution therapy by MTBE 
7.3.4.1 Efficacy ofMTBE therapy 
Thistle and co-workers from the Mayo Clinic [29] reported a success rate of 96% (72 of 
75 patients). Success was defined as a complete dissolution (N=21) or more than 95% 
dissolution (N =51). More than 95% dissolution was estimated on the basis of the change 
in stone size, as determined by catheter cholecystography. In the 51 patients with more 
than 95% dissolution, residual debris (fragments not larger than 5 mm in diameter) was 
detected by Ultrasonography. Only 15 of these 51 patients became ultimately stone free 
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after 6 - 35 months. A group from Frankfurt, Germany [30] also reported a success rate of 
96% (48 of 50 patients). However, criteria for success were not defined in this study. In 
an updated preliminary report from this group that to date have treated 231 patients, the 
success rate was still 96%. However, 40- 50% of the patients had "some sludge" in the 
gallbladder after successful stone dissolution [41]. The treatment time usually ranges over 
1 - 3 days with about 5 hours treatment each day. The total treatment time averaged 
between 9.5 hours (range 2.5 to 21 hours) [30] and 12.5 hours (range 3.8 - 30.8 hours) 
[29]. In 90% of the patients hospitalization is limited to 3-4 days [41]. 
7.3.4.2 Side effects ofMTBE therapy 
Puncture related complications have been discussed in section 7.2.3. Percutaneous 
transhepatic placement of a 5-F catheter for MTBE therapy is reported to be successful in 
most patients [29,30]. 
Reported side effects related to MTBE include: nausea with or without emesis, 
sedation, and the odour of MTBE on the breath. These symptoms are related to systemic 
absorption of MTBE. Approximately one third of the treated patients complained of these 
side effects [29,30,42,43]. All patients responded rapidly to anti-emetic drugs or transient 
cessation of solvent infusion. In most patients burning pain in the right upper quadrant 
required i.v. analgesics during the first hours of therapy [29]. Other causes of pain are 
postulated by Mueller [34]: extravasation of bile or MTBE along the catheter track, biliary 
colic due to stone fragments that may be displaced into the cystic or common duct during 
MTBE therapy, and catheter manipulations for optimal repositioning of the catheter. 
Serious side effects related to overflow of MTBE from the gallbladder to the bile ducts 
and duodenum are extremely uncommon. Thistle [29] reported one case with clinical signs 
of ulcerative duodenitis and intravascular hemolysis. Ponchon [43] described one patient 
who went into coma for 4 hours and subsequently developed acute renal failure. Hemo-
lysis was suspected to have caused the renal failure. No deaths have been reported related 
to percutaneous contact dissolution by MTBE. 
7 .3.4.3 Follow-up of MTBE therapy 
Data are sparse on long-term results after MTBE treatment. Only preliminary results from 
the Mayo Clinic are available [44]. They followed 117 patients treated with MTBE for 6-
48 months. Complete dissolution of stones was achieved in 36 patients (31 %). In 8 of 
these 36 patients, recurrence of gallstones was documented. Residual debris was present in 
81 patients; 15 of 81 patients became ultimately stone free and 34 other patients had 
doubled their residual debris ("regrowth"). 
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7 .3.5 Conclusions 
In his leading article "Nonsurgical treatment of gallstones: many contenders but who will 
win the crown?" Bouchier [45] gives his opinion on MTBE therapy: "This treatment is not 
for the faint hearted". With this statement Bouchier refers to the side effects of MTBE, 
such as nausea, vomiting and pain that makes this therapy uncomfortable for many 
patients. Moreover MTBE therapy is tedious, labour intensive and more invasive than 
other nonsurgical treatments such as ESWL and oral bile acids. On the other hand, rapid 
dissolution of cholesterol stones, irrespective of their number or size, can be achieved 
more effectively and quicker with MTBE than with oral bile acids or ESWL therapy. The 
reported high success rate of dissolution (96%) [29,30] includes residual debris in most 
patients. In a comment on the work of Thistle and co-workers at the Mayo Clinic, Auteri 
and Malet [46] take the view that the ultimate fate of this residual debris is the key 
question for the role of MTBE therapy. Questions that have to be answered are: to what 
extent will residual debris cause biliary symptoms? Will it spontaneously pass out the 
gallbladder or does it provide a nidus for rapid recurrence ("regrowth")? Can residual 
debris be avoided by a more precise selection of patients, perhaps by computed tomo-
graphy? Further studies on these issues should define the potential role of percutaneous 
local contact dissolution by MTBE for the treatment of gallstone disease. 
7.4 Percutaneous techniques for fragmentation and removal of gallbladder stones 
7.4.1 Introduction 
Interventional radiology of the biliary tract first attracted the attention of the lay press 
when Burhenne percutaneously removed a retained gallstone from the bile duct of the 
exiled Shah of Iran in 1979 [47]. In the following decade a plethora of percutaneous 
techniques for the management of gallstones became available. This section discusses the 
most important techniques for fragmentation and removal of gallbladder stones. 
Percutaneous techniques may be used in severely ill, high-risk patients with acute 
cholecystitis who need decompression of the gallbladder. If, after resolution of the 
inflammation, cholecystectomy remains contraindicated, the gallstones may be removed 
through a dilated cholecystostomy tract. Indications for elective removal of gallstones by 
percutaneous techniques are usually confined to morbidly obese patients and patients with 
high risk for anesthesia. In most cases there are no restrictions regarding the size, number 
and composition of the gallstones. Patient selection only requires the assessment of a safe 
access route to the gallbladder, as discussed in section 7 .2. 
87 
Chapter 7 
Table 7.1 Percutaneous fragmentation and removal of gallbladder stones 
Series No Indication Anesthesia 
(1) Rotational contact lithotripsy 
Miller 199150 10 elective local anesthesia 
i.v. analgesics 
i.v. sedatives 
(2) Percutaneous cholecystolithotomy 
Cope 198810, 199()-"4 20 elective epidural 
Lees.Kellet I988n. 19895~> 61 elective general 
Hruby 198957 11 elective general 
Grifith J99Cl' 13 dectiw general 
Akiyama I990S5 28 elective no data 
Kerlan 19855:! 3 acutt; local anesthesia 
i.v. analgesics 
i.v. sedatives 
Picus !989£< 11 acute local anesthesia 
i. v. analgesics 
i.v, sedatives 
(3) Combined SU11!ical and radiological intervention 
Burhenne 198559 • Gibnq 198760 36 acute local anesthesia 
i.v. analgesics 
i.v. sedatives 
Total 193 
NOTE: number of patients in parentheses 
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Access route 
transhepatic 
subhepatic anchor 
subhepatic 
subhepatic 
subhepatic 
transhepatic 
transhepatic 
transhepatic 
subhepatic 
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Maximal diameter 
tract 
10-F 
14-24-F 
28-F 
24-F 
25-F 
26-F 
24-F 
18-F 
24-F 
No of patients 
stone fr~ 
7 
17 
56 
9 
11 
20 
3 
11 
35 
169 
Complications 
access loss (1) 
biloma (I) 
bile leakage (1) 
Instrumental failure (l) 
access loss (1) 
vasovagal reaction (1) 
retained anchor (3) 
cholecystectomy due 
to failure (4) 
acce....;;s loss (1) 
cholecystitis (1) 
stone fragmentation failed (1) 
access loss (1) 
bile leakage (1) 
inability to access (1) 
bile leakage (2) 
bleeding (1) 
stone impaction cystic duct (2) 
wound infection (1) 
bileperitonitis t (1) 
access loss (1) 
colon injury (1) 
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Table 7 .l gives an outline of three groups of procedures which includes: 
I. percutaneous rotational lithotripsy [48-51] 
2. percutaneous cholecystolithotomy [10, 11 ,52-58] and 
3. combined surgical and radiological intervention [59-60]. 
7 .4.2 Percutaneous rotational lithotripsy 
A new method to fragment and remove gallstones was developed by Kensey and Nash who 
designed a device to pulverize calculi in a manner similar to that of a household blender 
[48]. The Kensey Nash lithotrite (Kensey Nash, Exton, PA,USA) consists of a six-
pronged basket which surrounds a 3 mm impeller mounted on a cable in a 7-F catheter. 
The basket protects the gallbladder wall from the impeller. An electric motor drives the 
impeller to rotate up to 30.000 RPM. A strong fluid vortex pulls the stones automatically 
into the basket and fragmentation to sizes mostly smaller than 2 mm is achieved within 
minutes [48,49]. Percutaneous cholecystostomy by means of a 10 F introducer sheath is 
performed to allow the introduction of the lithotrite into the gallbladder. General anesthe-
sia is not necessary, but as the procedure may be painful, adequate i.v. analgesics and 
sedation are required. After the procedure a 10 F catheter is left in place for 7-10 days to 
flush the gallbladder with saline and to aspirate residual debris. Moreover, in this period a 
tract develops which is required for safe removal of the catheter (section 7.2). 
Miller eta! reported the first clinical experience with the lithotrite in 10 patients [50]. 
The selection criteria for the treatment included: no limitations in the number of stones, 
but stone volume may not exceed 75% of the volume of the gallbladder. This restriction is 
necessary because the device must be able to open freely in the gallbladder. Stones up to 
25 mm in size, can be treated; the gallbladder should be visualized on oral cholecystograp-
hy (this criteria lapses in a sequel study [51]). The number of calculi varied between 1 to 
more than 25. In 9 of 10 patients the treatment was completed; in one patient access to the 
gallbladder was lost. The rotation time varied between 5-39 minutes. At the termination of 
the procedure 7 of 9 patients were stone free. Complications occurred in three patients: 
one patient with an infected biloma due to catheter dislodgement 12 hours after the 
procedure; one patient with transient bile leakage after removal of the catheter 9 days after 
the procedure and in another patient an instrumental failure occurred without injury to the 
gallbladder. 
The hospital stay ranged from 2-3 days. In the follow-up after 3-6 weeks, ultrasono-
graphy showed aggregates (3-4 mm) in three patients who were initially considered to be 
stone free at the end of the procedure. This phenomenon was explained by the authors 
according to observations in animal studies [48,49], that showed mucosal trauma with an 
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irregular gallbladder wall and some blood clots after treatment. Some stone fragments will 
temporarily adhere to the mucosa and will not be detected until they drop into the bile and 
clump together. Flushing with saline for some days after the procedure cannot totally 
prevent this phenomenon. In a preliminary report, results of 32 patients treated at 6 
centres were presented [51] and these results did not differ essentially from the first 10 
patients. 
Like local contact dissolution by MTBE, local contact lithotripsy with the Kensey Nash 
lithotrite has to deal with the consequence of residual debris. Nevertheless, compared to 
MTBE therapy, treatment with the lithotrite appeared to be more attractive. Differences 
between the two treatment modes are shown in Table 7 .2. 
TABLE 7.2 Comparison between MTBE and Lithotrite treatment 
MTBE Lithotrite 
Stone composition 
Stone number and size 
Treatment time 
Catheter size t:mployed 
cholesterol 
no limitation 
hours-days 
5-F 
all stones 
< 30 mm: < 75% gallbladder volume 
minutes 
10-F 
7 .4.3 Percutaneous cholecystolithotomy (PCCL) 
This method consists of a heterogeneous group of treatments with many modifications 
[10,11,52-58] (Table 7.1). They have the following steps in common: (!)percutaneous 
access to the gallbladder (2) dilatation of the tract (3) introducing instruments to fragment 
and remove gallstones (4) leaving a drainage tube in the gallbladder for a period of time. 
The access route to the gallbladder is discussed in section 7.2.1. Dilatation of the tract can 
be performed with fascial dilatators, co-axial systems or by balloon dilatation. The 
dilatation is painful and is a risk, particularly when a large tract is needed and a transhepa-
tic route is chosen. Therefore multiple sessions for gradual dilatation may be necessary. 
When a subhepatic route is chosen and general anesthesia is used, dilatation of a large tract 
can be achieved in one step [II ,56-58]. If the final tract to the gallbladder is established, 
small stones will leave the gallbladder spontaneously. Medium sized stones can be 
removed under fluoroscopic guidance with the use of baskets, graspers or forceps. Larger 
stones must be fragmented by techniques such as intracorporeal electrohydraulic lithotrip-
tors, ultrasound lithotriptors or laser. For these fragmentation techniques, direct visualiza-
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tion is enabled using flexible choledochoscopes [10,53-55], or rigid nephroscopes [11,56-
58]. Multiple sessions may be needed to extract all stones. Good results (Table 7.1) were 
reported (127 of 147 stone free = 86%), with relatively few complications. One death due 
to bile leakage after withdrawal of the catheter in a severely ill high-risk patient was 
reported [53]. Although these procedures are complex and technically demanding, 
percutaneous cholecystolithotomy appeared to be a safe and effective procedure in high-
risk patients, especially in those patients with acute cholecystitis in whom percutaneous 
decompression of the gallbladder is indicated. Some authors [11,56-58] advocate a one-
step procedure under general anesthesia as an elective treatment for patients who refuse 
surgery to avoid a prolonged hospital stay or a large abdominal scar. With the introduction 
of laparoscopic cholecystectomy this is no longer a viable alternative. 
7 .4.4 Combined surgical and radiological intervention 
This technique, introduced by Burhenne [59], is an example of good cooperation between 
surgeon and interventional radiologist. After localizing the gallbladder with ultrasonograp-
hy, the surgical part consists of a minicholecystostomy performed under local anesthesia. 
A small (± 5 em) abdominal incision is made over the marked gallbladder fundus and a 
pursestring suture is made in the fundus of the gallbladder. Within this suture a small 
incision is made to introduce a 24-F catheter in the gallbladder. The fundus of the 
gallbladder is than stitched on each side of the combined peritoneum and posterior rectus 
sheet layer, thus creating a short surgical tract. After 7-10 days the radiological interventi-
on for stone removal can be performed, using techniques similar to those employed for 
PCCL. This method is claimed to be safe and effective (Table 7.1). Burhenne preferred it 
for high-risk patients for the following reasons [60]: (I) the surgical procedure avoids the 
painful and hazardous dilatation of a percutaneous track (2) in case of recurrence, 
subsequent percutaneous cholecystostomy is easy because of the superficial location of the 
fixed fundus of the gallbladder (3). Vaso-vagal reactions following percutaneous cholecys-
tostomy are avoided. Nevertheless this technique has not gained widespread acceptance. 
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SCLEROTHERAPY OF THE GALLBLADDER IN PIGS: 
Development of a balloon catheter for a single-step procedure 
8.1 Abstract 
Gallbladder sclerotherapy after permanent cystic duct occlusion, to prevent gallstone 
recurrence in nonsurgical gallstone therapy, is at least a two-stage procedure. A balloon 
catheter was developed to perform gallbladder sclerotherapy with only temporary 
occlusion of the cystic duct, and the efficacy and safety of this method was subsequently 
investigated. Twenty pigs underwent cholecystostomy for positioning of a 7-F triple lumen 
balloon catheter with proximal side holes. Sclerotherapy with 96% ethanol and 3% sodium 
tetradecyl sulfate for 20 minutes was performed. 
The animals were killed 24 hours, two, six and 12 weeks after the procedure. 
The balloon catheter functioned well and seems suitable for procedures in which a 
temporary occlusion of the cystic duct is required. 
Although gallbladders after six and 12 weeks were shrunken and fibrotic, a single 
treatment of gallbladder sclerotherapy with subsequent catheter removal and no permanent 
cystic duct occlusion, as performed in this experiment did not produce complete 
gallbladder ablation. In this study, sclerotherapy proved safe in the short term, but long-
term effects remain to be assessed. 
8.2 Introduction 
The introduction of extracorporeal shockwave lithotripsy (ESWL) of gallstones has 
stimulated interest in other nonsurgical treatment modalities for gallstone disease. 
Radiological intervention techniques play a major role in this field, including several 
techniques for fragmentation and percutaneous removal[l-4] or direct contact dissolution 
[5-8] of gallbladder stones, and also ablation of the gallbladder. 
Published as:Koen Brakel,M.D., Johan S. Lam~ris.M.D., Henk Vergunst,M.D., Fiebo J.W. ten Kate,M.D, 
Huub G.T. Nijs.M.D .• Onno T. Terpstra.M.D .. SCLEROTHERAPY OF THE GALLBLADDER IN PIGS: 
Development of a balloon catht:ter for a single-step procedure. Invest Radio I 1991; 26:804-809 
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Several authors have reported results of in situ gallbladder ablation. Permanent 
occlusion of the cystic duct preceding chemical sclerosing of the gallbladder mucosa has 
been reported as successful [9-11], but have been unable to reproduce this method success-
fully [12]. 
Good results also have been reported without permanent occlusion of the cystic duct [13]. 
Because permanent cystic duct occlusion followed by gallbladder sclerosing is at least a 
two-stage procedure, we have attempted to develop a one-step procedure in which stone 
treatment and gallbladder sclerosing could take place. 
This study was initiated to test a balloon catheter developed for radiological 
interventional procedures with temporary cystic duct occlusion, and to investigate the 
safety and efficacy of gallbladder sclerotherapy with only temporary occlusion of the 
cystic duct. 
Figure 8.1 The 7-F triple-lumen balloon catheter.(a)Proximal portion with three separate lumina. (b)Distal 
portion with proximal side holes (arrow), balloon. and an end hole. 
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8.3 Materials and Methods 
Animals 
Twenty young Yorkshire pigs (average weight 28 kg) were used for the experiments. 
Before the procedure, they were fasted overnight. After premedication with ketamine IM 
(30 mg/kg) and intratracheal intubation, inhalation anesthesia was maintained with 
oxygen, nitrous oxide and enflurane. Fentanyl citrate and pancuronium bromide were used 
for IV analgesia and muscle relaxation, respectively. A single IM dose of 2.0 to 2.5 ml 
Depomycin 20/20® (penicillin G 200,000 U/ml, streptomycin 200 mg/ml, Mycofarm, de 
Bill, The Netherlands) was given as antibiotic prophylaxis. 
Positioning ofthe balloon catheter 
After localizing the gallbladder with sonography, a median longitudinal incision (7-10 em) 
at the level of the gallbladder was made. The gallbladder was mobilized and a small 
pursestring suture with proleen 3.0 was made in the fundus of the gallbladder. Within this 
suture the gallbladder was punc-
tured to evacuate bile and to 
introduce a specially designed 7-
F triple lumen balloon catheter 
with proximal side holes and an 
end hole (Cook Company, Eind-
hoven, The Netherlands; de-
signed by J.S. Lameris, MD) 
(Fig. 8.1). 
After flushing and filling the gall-
bladder with saline through the 
catheter, a J -shaped guide wire 
(0.035 inch) was inserted into the 
cystic duct to enable positioning 
of the balloon in the cystic duct. 
The balloon was then insufflated 
with air and the gallbladder was 
emptied and completely filled 
with contrast (16-20 ml Telebrix, 
Guerbet, Aulnay S/Bois, France) 
to control the position of the 
balloon and complete occlusion 
of the cystic duct (Fig. 8.2). 
Figure 8.2 Radiograph of the abdomen after filling the 
gallbladder with contrast to control the position of the balloon 
(arrows). The cystic duct is completely occluded: there is no 
1\!akage of contrast in the bile duct. 
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In the event of leakage at the introduction site of the catheter in the fundus of the gallblad-
der, the fluid was cleared with gauze steeped in saline. 
Sclerotherapy 
After evacuating the contrast, the gallbladder was filled with a similar amount of 
sclerosing agent (96% 
ethanol with 3% sodium tetradecyl sulfate) over the course of 20 minutes. Thereafter the 
sclerosing agent was aspirated, and the gallbladder was flushed with saline. After 
withdrawal of the catheter, the gallbladder pursestring and the abdomen were closed. 
Blood samples (white blood count, aspartate aminotransferase, alanine-aminotransferase, 
alkaline phosphatase, amylase) were taken before and after the procedure and just before 
the animals were killed. Serum ethanol levels were determined immediately before the 
removal of the sclerosing agent. 
Macroscopic studies 
The pigs were divided into four groups of five animals each; these were killed after 24 
hours, two weeks, six weeks and 12 weeks. 
Ultrasonography was performed before the procedure and before autopsy. At autopsy, the 
intra-abdominal organs were carefully inspected for macroscopic lesions. The liver, 
biliary tract, and gallbladder were resected en bloc and fixed in phosphate buffered 
formalin. Specimens for histologic investigation were obtained from the fundus and corpus 
of the gallbladder, the transitional zone of gallbladder neck and proximal cystic duct, and 
the distal cystic duct, common bile duct and porta hepatis, all with adjacent liver tissue. A 
control specimen was taken from a distant liver area. Sections were stained with hema-
toxylin-azophloxin-saffron (HAS). 
Microscopic studies 
Histologic data were recorded on standardized forms by a experienced hepatobiliary 
pathologist (FJWK), who was uninformed about the assigned group. 
Data analysis 
Statistical evaluation of the laboratory data was performed by the Mann-Whitney U test. 
This protocol was approved by the committee on Animal Research of the Erasmus 
University, Rotterdam, The Netherlands. 
8.4 Results 
8.4.1 Balloon Catheter 
There were no catheter-related problems during the procedure. The cystic duct could be 
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completely occluded by the balloon in all cases. 
In one animal, killed after 2 weeks, the cystic duct displayed localized deep inflammation 
of the wall with necrosis and fibrosis, probably related to mechanical injury from the 
balloon. No other lesions were found in the cystic duct. 
8.4.2 Sclerotherapy of the gallbladder 
Safety 
In II of 20 procedures, at maximal filling of the gallbladder, leakage of some drops of 
gallbladder content (saline, contrast, sclerosing agent) occurred at the introduction site of 
the balloon catheter in the fundus of the gallbladder. The serum ethanol concentration did 
not reach the detection rate (0.1 gr/1) in any animal. Each pig served as its own control for 
evaluation of laboratory parameters. A minor increase in mean white blood count (P < 
0.05) was observed one day after the procedure. The mean serum activity of aminotransfe-
rase aspartate was elevated in all groups of animals immediately after the procedure 
(maximum increase 1.9-fold) (P < .05), but was restored to baseline values at the time of 
killing. No other significant changes in laboratory findings were observed. 
All pigs survived the procedures and were in good health until they were killed. 
At autopsy, no free fluid was present in the abdomen. In the II animals with gallbladder 
leakage, mild adhesions in the pericholecystic area and small superficial lesions on the 
liver surface were observed. Two pigs suffered from an intraperitoneal encapsulated 
abscess, one as a result of a gauze that was left behind, the other with a fistula from the 
gallbladder. No other macroscopic lesions were found. 
At microscopic investigation, bile duct specimens showed nonspecific mild chronic 
inflammation. Damage to the liver was restricted to a small region of the gallbladder 
fossa, and was most clearly seen in the group killed at 24 hours, showing as mild to 
moderate acute inflammation in four of the five animals. In the other groups (killed at 2 
weeks, 6 weeks, 3 months) only three of the 15 pigs showed mild fibrosis and/or mild to 
moderate chronic inflammation. All liver specimens, included those from a distant liver 
area, showed very mild chronic portal inflammation. 
Efficacy 
At autopsy, all gallbladders were shrunken, with a mean volume of 2.5 ml (range: 0.5-7.5 
ml) while the mean volume before the procedure was 18 ml (range: 16-20 ml). Most of the 
gallbladders contained solid material, with fibrin, mucin, and bile. The results of the 
histologic investigations of the gallbladder are shown in Table 8. L Following sclero-
therapy in each group of animals, a characteristic sequence of changes in the gallbladder 
wall was observed. 
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In the group of animals killed after 24 hours, the predominant finding was edema of the 
entire gallbladder wall (Fig. 8.3a). In two pigs from this group there were signs of 
necrosis and extensive proliferation of fibroblasts (active fibrosis). Local regeneration of 
the epithelial lining had started in the form of a monolayer of cylindrical mucus secreting 
cells. 
In the group of animals killed after two weeks, coagulation necrosis of the mucosa, 
which was rejected as a membrane, was prominent (Fig. 8.3b). Regeneration was also 
present, starting from isolated islands of intact mucosa. In the groups killed after six and 
12 weeks, in seven of eight pigs moderate to strong fibrosis was observed. A regenerated 
epithelial lining was evident, consisting of a monolayer of cylindrical mucus secreting 
cells covering the atrophic mucosa (Figure 8.3c). 
Table 8.1 Histolo~ic appearance of the gallbladder after sclerotherapy~ 
group edema necrosis inflammation actiV<! r..::generation inactive 
No. fibrosis mucosa fibrosis 
24hrs +++ 0 + 0 0 0 
2 ++ ++ + ++ + 0 
3 +++ 0 + 0 0 0 
4 ++ ++ + + + 0 
5 +++ 0 + 0 0 0 
2wks 0 +++ ++ +++ + 0 
2 0 +++ ++ ++ + 0 
3 0 +++ ++ +++ + 0 
4 0 + + ++ + 0 
5 + +++ + +++ + 0 
6wks 0 0 0 0 +++ ++ 
2 0 0 + 0 +++ ++ 
3 0 0 + 0 +++ +++ 
4 
5 0 0 0 0 +++ + 
12 wks 0 0 + 0 0 + 
2 0 0 0 0 +++ +++ 
3 0 0 + 0 +++ ++ 
4 
5 0 0 0 0 +++ ++ 
") O:absent: +:mild: + +:moderate: +++:strong: -:not available for analysis due to autolysis of 
histologic material 
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Figure 8.3 Histologic sections of the gallbladder 
(Hematoxylin-azophloxin-saffron; original mag-
nification x 150). 
(a) twenty-four hours after sclerotherapy. there is 
an extensive edema of the entire gallbladder wall 
(W) and adventitia betw¢.m the liver (L) and 
gallbladder. A dilated lymph vessel (LV) is promi-
nent in the adventitia (M: mucosa). 
(b) Two weeks after sclerotherapy, the mucosa 
(M) shows coagulation necrosis. A fragment of 
desquamated mucosa (D) is seen in the gallbladder 
lumen. The entire gallbladder wall shows active 
fibrosis. 
(c) Six and 12 weeks after sclerotherapy, the gall-
bladder wall (W) displays a strong diffuse fibrosis. 
A complete regenerated epithelial lining (E) covers 
the atrophic mucosa (M). 
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8.5 Discussion 
We developed and tested a balloon catheter to investigate the efficacy and safety of 
gallbladder sclerosing with only temporary occlusion of the cystic duct. 
The specially designed balloon catheter for temporary cystic duct occlusion proved to 
be effective in our pig model. The catheter can serve as a useful tool for interventional 
procedures such as sclerotherapy of the gallbladder and local contact dissolution of 
gallstones. During the sclerotherapy, the cystic duct was occluded completely without 
leakage of gallbladder content into the bile ducts. 
The diameter of the balloon (8 mm) was sufficient to occlude the cystic duct without 
tissue damage. The side holes situated 30 mm proximal to the balloon functioned efficient-
ly for both installation and evacuation of the sclerosing agent. We are currently developing 
a modification of the catheter in which the proximal side holes are situated in an additional 
loop of the catheter; this will be especially suitable for local dissolution therapy. The third 
lumen with the end hole is used for insertion of the guide wire and can also be used for 
flushing the bile duct during deflation of the balloon at the end of the procedure. 
To gain access to the gallbladder, we performed a cholecystotomy after a minilaparoto-
my, because the porcine gallbladder is situated subhepatically and is very mobile [14]. In 
11 of 20 procedures with this method, leakage of some drops of gallbladder content 
occurred at the gallbladder fundus, where the balloon catheter was inserted. In humans, 
leakage can be prevented by percutaneous transhepatic access, or by a subhepatical 
approach using a currently available anchoring device [15]. 
Our findings indicate that sclerotherapy of the gallbladder with only temporary 
occlusion of the cystic duct is a safe procedure. No toxic effects or hepatic injury related to 
the sclerotherapy were found. 
Although the one-step procedure with a balloon catheter for gallbladder sclerotherapy 
resulted in a shrunken fibrotic and defunctionalized gallbladder in all animals, we did not 
succeed in destroying the mucosa completely, and therefore ablation was not achieved. In 
our opinion this can be explained by the following observations. 
First, the regenerative capacity of the gallbladder mucosa plays an important role. In 
this animal model it was remarkable how quickly (within 24 hours) extensive mucosal 
regeneration occurred from little islands of still-viable mucosa. Although there might be 
further refinements in sclerotherapy, such as longer duration of the therapy or different 
administration regiments with different sclerosing agents, we consider it virtually 
impossible to achieve total destruction of the mucosa. In this study, introduction of even a 
small air bubble in the gallbladder during installation of the sclerosing agent was sufficient 
to cause such islands of undestroyed mucosa. Becker et al [11], who reported very good 
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results of sclerotherapy in pigs, also found occasional "nests" of epithelium in five of 16 
animals. Perhaps their use of a 22-F cholecystotomy catheter with a large balloon situated 
in the gallbladder fundus made it impossible for the sclerosing agent to reach the mucosa 
at that site, and contribute to the creation of "nests" of epithelium. 
Further, in humans with almost inaccessible sinuses of Aschoff-Rokitansky, these 
remnants of undestroyed mucosa seem to be an even greater problem [16]. Therefore it is 
not surprising that Becker and coworkers in humans [17] were unable to reproduce the 
good results as they achieved in animals [II]. 
The long term effects of remnants of undestroyed mucosa remain unknown, and the 
potential risk for malignant transformation should be considered. A second possible 
explanation for failure to achieve total mucosal destruction in this study is that the cystic 
duct was not permanently occluded. Although, in contrast to Getrajdman eta! [10], we did 
not observe mucosal regeneration from the cystic duct, almost all gallbladders in our study 
contained material with fibrin, mucin and bile. Thus, as suggested by Becker et a! [11], 
obliteration of the gallbladder lumen will be hampered. On the other hand, leaving a 
catheter in the gallbladder for a certain time period could have been an appropriate 
solution for this problem. We chose temporary occlusion with a balloon catheter, and 
subsequent catheter removal, in the search for a single-step procedure. The ultimate goal 
of this therapy is to achieve gallbladder ablation, which prevents recurrence of gallstones 
and avoids risks such as mucocele and malignancy, because ablation implies that no 
endothelium or adenomatous remnants remain. 
Since gallstone recurrence is a problem predominantly in young people, this therapy 
offers most to this age group. However, as the long-term effects of this treatment are 
unclear, the indication for sclerotherapy is, especially for young people, doubtfuL 
Moreover in this group of patients this therapy has to "compete" with surgical therapy, of 
which laparoscopic cholecystectomy seems to be a less invasive and promising therapy 
[18]. 
We conclude that: 
1) The triple lumen balloon catheter is suitable for radiological interventional procedures 
in which a temporary occlusion of the cystic duct is required. 
2) A single treatment of gallbladder sclerotherapy with subsequent catheter removal and 
no permanent cystic duct occlusion as performed in this experiment does not produce 
complete gallbladder ablation. 
3) Although sclerotherapy is proven safe in the short term, long-term effects on remnants 
of undestroyed mucosa remain to be assessed. 
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FINAL REMARKS 
An imaging strategy for patients suspected of gallstone disease 
The management of gallstone disease has changed rapidly during the last few years. 
Studies described in this thesis were initiated four years ago, when first reported results of 
gallstone lithotripsy aroused hopes for a new era in the management of gallstone disease. 
Because ESWL fell short of these high expectations and laparoscopic techniques made 
surgical therapy more attractive, it is now expected that nonsurgical gallstone treatment 
will play only a limited role. Nevertheless, most of these nonsurgical treatments have 
proven to be safe and effective in selected patients. Therefore nonsurgical treatment 
modalities should be part of the armamentarium in the management of gallstone disease. 
The treatment of choice for patients with symptomatic gallstone disease depends on: (1) 
the patient's state of health, (2) the need for emergency or elective treatment, (3) radio-
logical selection criteria and ( 4) the preference of the patient. 
One of the aims of this thesis was to design an imaging strategy for patients with 
symptomatic gallstone disease. The ideal imaging strategy consists of an efficient sequence 
of imaging modalities, able to assess selection criteria for the different gallstone treatment 
modalities in a reliable, safe and cost effective manner. Success of nonsurgical treatment is 
highly dependent on precise selection. Therefore the cost of the selection procedure should 
be outweighed against costs generated by ineffective treatment in patients not selected 
properly. For an effective patient selection it is essential to be aware of the selection 
criteria at the time of diagnosis. Ultrasonography (US) is the first diagnostic modality to 
detect gallbladder stones. Once the diagnosis of gallstones is made by US, additional 
information for selection purposes should be obtained during the same examination. 
The value of US in providing this information was a subject of study in this thesis 
(chapters 2 and 3): 
In chapter 2, the value of US in providing information concerning the so-called 
"function" of the gallbladder was investigated. Oral cholecystography (OCG) is con-
sidered to be the standard test for this selection criterion. Gallbladder visualization on 
OCG is required for most nonsurgical treatments of gallstones because it ensures both 
cystic duct patency and concentration capability of the gallbladder. The results presented 
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in chapter 2 show that US findings such as a contracted stone-filled gallbladder or an im-
pacted gallstone in the cystic duct or the gallbladder neck are highly specific in predicting 
non-visualization of the gallbladder on OCG. Therefore patients with these findings are 
not eligible for most nonsurgical treatments. Nevertheless in case of stone impaction there 
could be a role for ESWL, since such therapy may re-establish cystic duct patency. 
In chapter 3, the accuracy of US and OCG in assessing the number and size of 
gallstones was investigated. From this study it is concluded that, although both US and 
OCG have some limitations in assessing the number and size of gallstones, both US and 
OCG are suitable for selection purposes concerning this selection criterion. However, with 
respect to US, one has to be aware of the following restrictions: 
-In case of more than one stone, US can only roughly estimate the total number of stones. 
- US will mostly underestimate the size of the gallstones and detection of gallstones larger 
than 30 mm has proved problematic with US. 
With careful attention to these selection criteria, a major part of the information that is 
needed for proper selection can be obtained with US at the time that the diagnosis of 
gallstone disease is made. The next step in the sequence of imaging modalities depends on 
the treatment options that remain eligible and that will be preferred. 
The sequence of imaging modalities needed for proper selection for each treatment option 
are now discussed separately: 
I (Laparoscopic) cholecystectomy 
US alone is sufficient. No further radiological selection is needed. 
2 Percutaneous techniques for fragmentation and removal of gallstones 
US alone is sufficient. Only in rare cases when there is doubt concerning a safe 
percutaneous puncture route, computed tomography (CT) will provide additional 
information. 
3 Oral bile acid therapy, ESWL 
Visualization of the gallbladder on OCG is mandatory for these treatments. Therefore, 
the next imaging modality that should be performed is OCG. 
4 Oral bile acid therapy, local contact dissolution with methyl tert-butyl ether 
(MTBE) 
For these treatments, one has to be informed about the chemical composition of the 
gallstones because only cholesterol stones will be dissolved. 
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OCG has limitations in discriminating between cholesterol and pigment stones. Floating 
gallstones at OCG is considered a specific sign for cholesterol stones [1], but is unfor-
tunately an infrequent finding (35% of cholesterol stones [I]; 19% of radiolucent stones 
[2]). The classic radiographic criterion to distinguish cholesterol from pigment stones is 
radiolucency c.q. radiopacity on plain abdominal radiography or OCG. This criterion is 
unreliable and CT has proven to be more reliable in predicting gallstone composition 
(chapter 4). Nevertheless, the use of CT for stone characterization has not gained 
widespread application. Reasons for this were summarized by Brink and Ferrucci [3]: 
including, variable accuracy, cumbersome interpretive algorithms and high costs. 
Indeed the CT defined cutoff point to discriminate between cholesterol and pigments 
stones varies in different studies from 50 to 140 HU. However, comparison of CT 
numbers from different studies without the use of a reference calibration phantom is 
impossible (chapter 4). Different CT systems produce different CT numbers, which is 
illustrated in chapter 4 and 5. In these studies CT scans were obtained with different CT 
systems (chapter 4: Tomoscan 350, Philips Medical Systems, Eindhoven, The Nether-
lands; chapter 5: Somaton CR, Siemens AG, Erlangen, Germany). For the rest, the 
studies described in chapter 4 and 5 have identical study designs with respect to CT and 
chemical analysis. The results were similar with respect to the high correlation between 
the mean CT numbers and the cholesterol or the calcium contents, but differed with 
respect to the defined cutoff point to discriminate between pure cholesterol and non-
cholesterol stones (140 HU in chapter 4 vs llO HU in chapter 5). 
Besides these practical problems it is still uncertain to what extent CT is able to predict 
successful outcome of nonsurgical therapy. To solve this problem one has to deal with the 
question: which type of stones will be most amenable for a successful treatment (i.e. com-
plete stone clearance)? It seems that the classic distinction between cholesterol stones and 
pigment stones is not sufficient for this purpose. 
Using oral bile acid therapy, several authors [4-6] reported significant higher dis-
solution rates for floating stones as assessed with OCG compared to non-floating stones. 
Malet and co-workers [2] hypothesized that this was due to their findings that buoyancy of 
gallstones indicates a subset of cholesterol stones with relatively low content of calcium 
salts. 
A comparable subset of gallstones was defined with the use of CT. Baron and co-
workers [7] reported a good correlation between CT patterns and in vitro MTBE dis-
solution rates. Highest dissolution rates were achieved in gallstones with faint or isodense 
CT patterns (these patterns are comparable with detectable and nondetectable noncalcified 
gallstones as described in chapter 4). 
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In vitro studies did not shown any relationship between quantitative CT analysis or CT 
patterns and adequate fragmentation of gallstones by ESWL (chapter 5). Nevertheless, Ell 
and co-workers [8] reported in a recent study some interesting findings with respect to the 
utility of CT as selection tool for patients treated with ESWL and adjuvant oral bile acid 
therapy. In this study 111 patients with solitary radiolucent stones underwent CT exami-
nation before treatment. Based on maximum CT numbers, patients were categorized into 
three groups: group A, < 50 HU, group B > 50 HU and < 90 HU, group C > 90 HU. 
A significant higher degree of stone disintegration and stone clearance was found in 
gallstones of group A compared to groups B and C. Because group A represents noncal-
cified gallstones at CT and groups B and C represent calcified gallstones at CT, quan-
titative CT analysis seems not necessary to distinguish group A from groups Band C. 
In conclusion, adequate treatment results of nonsurgical gallstone therapy may only be 
expected with a subset of cholesterol stones with low or absent contents of calcium salts. If 
this is the case one can formulate two criteria to select this subset of cholesterol stones: 
(1) buoyancy as assessed with OCG (20% of radiolucent stones) (2) noncalcified stones on 
CT (± 50% of radiolucent stones). 
Finally, an imaging strategy to diagnose and select patients suspected of gallstone disease 
is summarized in the following flow chart (figure 9. 1): 
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Figure 9.1 flow chart of an imaging strategy to diagnose and select patients suspected of gallstone disease 
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Nonsurgical therapy of gallbladder stones has fundamently changed the role of radiology 
in the management of gallstone disease. Aspects of this new role, both in diagnostic 
imaging and in interventional radiology are the subjects of this thesis. 
Chapter I gives an outline of the currently available surgical and nonsurgical treatment 
modalities for the management of symptomatic gallbladder stones, and the aims of the 
thesis are formulated. 
Chapter 2 presents the results of a study in which we attempted to establish sonographic 
criteria which will predict non-visualization of the gallbladder on oral cholecystography 
(OCG). Ultrasound (US) and OCG findings have been compared in 171 patients with 
symptomatic gallstones. The results show that US findings, such as a contracted 
gallbladder or an impacted gallstone in the cystic duct or in the gallbladder neck, are 
highly specific in predicting non-visualization of the gallbladder on OCG. Patients with 
a contracted gallbladder on US are not suitable for nonsurgical therapy of gallbladder 
stones. In case of an impacted gallstone, there could be a role for extra corporeal 
shockwave lithotripsy (ESWL) because this therapy may re-establish cystic duct 
patency. 
Chapter 3 reports on the accuracy of US and OCG in assessing the number and size of 
gallstones. The results show that both US and OCG have some limitations to count and 
measure gallstones. Combining examinations does not improve the results. Both US and 
OCG are suitable for selection purposes, but one has to be aware of the following 
restrictions: I) In case more than one stone is present, US can only roughly estimate the 
number of stones. 2) US proves more reliable than OCG in discriminating gallstones 
smaller or larger than 10 mm and smaller or larger than 20 mm, but with US detection 
of gallstones larger than 30 mm has proved problematic. 3) With both US and OCG the 
size of the gallstones are underestimated. 
Chapters 4 & 5 are devoted to the potential role of computed tomography (CT) in the 
prediction of the chemical composition of gallstones. 
Chapter 4 presents the results of in vitro and in vivo CT analysis of gallstones which 
have been compared with plain abdominal radiography or OCG. Chemical analysis of 
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the gallstone composition served as the standard of reference. High correlations between 
mean CT attenuation numbers (HU) and either cholesterol or calcium content are found 
in vitro as well as in vivo. Using a cutoff point of 140 HU, pure cholesterol stones (;;, 
80% cholesterol) and noncholesterol stones can be discriminated far more accurately by 
in vitro and in vivo CT compared to plain abdominal radiography or OCG. 
Cfulpter 5 describes a similar study design with respect to the relationship between in 
vitro CT characteristics and chemical gallstone composition. The CT system (Somaton 
CR, Siemens AG, Erlangen, Germany) differs from the one used in the study described 
in chapter 4 (Tomoscan 350, Philips Medical Systems, Eindhoven, The Netherlands). 
The results reveal similar high correlations between mean CT attenuation numbers and 
either cholesterol or calcium content. Only the defined cutoff point to discriminate 
between pure eholesterol stones and noncholesterol stones differs: from 140 HU in 
chapter 4 versus 110 HU in chapter 5. This illustrates that different CT systems produce 
different CT attenuation numbers. 
The study described in chapter 5 also examines the relationship between in vitro CT 
characteristics and in vitro fragmentation by ESWL; no relationship was found. 
Chapter 6 discusses the follow-up of patients after nonsurgical therapy of gallbladder 
stones. In order to establish the value of US in the follow-up of patients treated with 
ESWL, the results of 484 US examinations of 87 patients are analyzed and related to 
the results of ESWL. The reliability of US to assess stone fragmentation and/or 
clearance following treatment with ESWL is investigated by comparing consecutive US 
examinations. In 7 patients the efficacy of ESWL is overestimated by US due to 
incorrectly demonstrating no fragments. In 9 patients delay in retreatment with ESWL 
was due to underestimation of the fragment size by US. It is also found that US findings 
indicative for hampered stone migration, such as a contracted gallbladder or a common 
bile duct diameter > 7 mm, indicates poor efficacy of ESWL. 
Chapter 7 gives a review of the literature of percutaneous techniques for the treatment 
of gallbladder stones. The technical aspects of percutaneous cholecystostomy and the 
possibilities and limitations of the currently available techniques for percutaneous 
fragmentation and removal, or direct contact dissolution of gallbladder stones, are 
discussed. 
Chapter 8 deals with the problem of gallstone recurrence following nonsurgical therapy 
of gallbladder stones. This can be prevented by chemical ablation of the gallbladder by 
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percutaneous administration of sclerosing agents. A triple lumen balloon catheter was 
developed to perform gallbladder sclerotherapy with only temporary occlusion of the 
cystic duct, and the efficacy and safety of this method is subsequently investigated in 
the pig model. The balloon catheter functioned well, the procedure was safe on a short-
term basis, but complete ablation of the gallbladder is not achieved. Long-term effects 
on remnants of undestroyed mucosa remain to be assessed. 
Chapter 9 discusses the results from the studies described in the chapters 2, 3 and 4 and 
recent reported data within the scope of an imaging strategy for patients suspected of 
gallstone disease. 
Finally a flow chart for an imaging strategy is presented. 
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SAMENVATTING 
Niet chirurgische behandeling van galblaasstenen, heeft de rol van de radiologie in de 
diagnostiek en behandeling van galsteenziekte fundamenteel veranderd. 
Aspecten van deze nieuwe rol, zowel op het gebied van de beeldvormende diagnostiek 
als op het gebied van de interventie radiologie zijn het onderwerp van deze studie. 
Hoofdstuk 1 geeft een overzicht van de op dit moment beschikbare chirurgische en niet 
chirurgische behandelingsmethodes voor symptomatisch galsteenlijden. De doel-
stellingen van het onderzoek worden geformuleerd. 
Hoofdstuk 2 geeft de resultaten weer van een studie waarin getracht is echografische 
criteria vast te stellen voor het voorspellen van een niet visualiseerbare galblaas op een 
oraal cholecystogram (OCG). Hiertoe werden bij 171 patienten met symptomatisch 
galsteenlijden de echografische en OCG bevindingen met elkaar vergeleken. 
Echografische bevindingen zoals geschrompelde galblaas, geimpacteerde steen in de 
ductus cysticus of in de galblaashals, zijn specifieke tekenen die het niet zichtbaar 
worden van de galblaas op een OCG kunnen voorspellen. Patienten waarbij deze 
tekenen worden gevonden kornen niet in aanmerking voor niet chirurgische behandeling 
van galblaasstenen. Aileen wanneer een geimpacteerde steen aanwezig is zou 
behandeling met extracorporele schokgolf lithotripsie (ESWL) een gunstig resultaat 
kunnen hebben zodat de ductus cysticus weer normaal doorgankelijk word!. 
Hoofdstuk 3 behandelt de nauwkeurigheid waarmee echografie en OCG het aantal en de 
grootte van galstenen kan vaststellen. Zowel echografie als OCG lomnen het aantal 
stenen en de grootte daarvan slechts in beperk"'e mate vaststellen. Oak met beide 
onderzoeksmethoden samen wordt het resultaat er niet beter op. Niettemin kunnen 
zowel echografie als OCG worden toegepast voor selectie doeleinden, mits men zich 
bewust is van de volgende beperkingen: 1) Indien meer dan een steen aanwezig is, kan 
bet aantal aanwezige galstenen slechts ruwweg geschat worden d.m. v. echografie. 
2) Echografie is betrouwbaarder dan OCG in het onderscheid maken tussen galstenen 
kleiner of groter dan 10 rom en kleiner of groter dan 20 mrn; echter, het vaststellen van 
galstenen groter dan 30 mm is echografisch moeilijk. 3) De ware grootte van de 
galstenen wordt zowel met behulp van echografie als met behulp van OCG onderschat. 
117 
Samenvatting 
De Hoofdstukken 4 & 5 behandelen de rol van computer tomografie (CT) in het 
voorspellen van de chemische samenstelling van galstenen. 
Hoofdstuk 4 toont de resultaten van in-vitro en in-vivo CT analyse welke wordt 
vergeleken met bevindingen bij bet blanco buikoverzicht of het OCG. De uitkomst van 
de chemische analyse van de samenstelling van de galstenen diende als gouden 
standaard. De gemiddelde CT getallen (HU) en zowel het cholesterol- als het calcium 
gehalte van de galstenen zijn zowel in-vitro als in-vivo, sterk gecorreleerd. Bij een 
"cutoff point" van 140 HU lamnen met behulp van CT pure cholesterol stenen ( > 80% 
cholesterol) en "noncholesterol" stenen vee! nauwkeuriger van elkaar worden 
onderscheiden dan met behulp van het blanco buikoverzicht of het OCG. 
Hoofdstuk 5 beschrijft een studie met een identieke opzet voor wat betreft de relatie 
tussen bevindingen bij in-vitro CT analyse en de chemische samenstelling van galstenen. 
De CT analyse werd in hoofdstuk 5 uitgevoerd op een Somaton Plus (Siemens AG, 
Erlangen, Duitsland) en in hoofdstuk 4 op een Tomoscan 350 (Philips Medical Systems, 
Eindhoven, Nederland). De gevonden correlaties tussen de gemiddelde CT getallen en 
zowel het cholesterol- als het calciumgehalte van de galstenen zijn identiek aan de 
gevonden correlaties in hoofdstuk 4. Alleen het "cutoff point" om onderscheid te 
kunnen maken tussen pure cholesterol stenen en "noncholesterol" stenen is in de studie 
beschreven in hoofdstuk 4 vastgesteld op 110 HU in plaats van 140 HU, zeals in de 
studie beschreven in hoofdstuk 5. Hiermee word! gelllustreerd dat verschillende CT 
apparaten verschillende CT nummers voonbrengen. 
In hoofdstuk 5 werd ook de relatie onderzocht tussen in-vitro CT analyse en in-vitro 
vergruis resultaten; er kon geen relatie worden aangetoond. 
Hoofdstuk 6 heeft betrekking op de follow-up van patienten die behandeld zijn met een 
niet chirurgische therapie voor galsteenlijden. Wij beperhen ons tot de bestudering van 
de waarde van echografie in de follow-up van patienten behandeld met ESWL. Voor dit 
doel werden de resultaten van 484 echo onderzoeken bij 87 patienten geanalyseerd en 
vergeleken met de behandelresultaten van ESWL. De betrouwbaarheid van echografie 
voor bet vaststellen van de behandelingsresultaten van ESWL werd onderzocht door de 
opeenvolgende echografische onderzoeken met elkaar te vergelijken. 
Op basis van deze echografische bevindingen zijn 7 patienten ten onrechte steenvrij 
verklaard. Bij 9 patienten is een noodzakelijke herbehandeling met ESWL pas later 
uitgevoerd omdat aanvankelijk de steenfragmenten echografisch ten onrechte te klein 
zijn gemeten. 
Uit deze studie blijh ook dat echografische bevindingen, zoals een geschrompelde of 
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samengevallen galblaas of een ductus choledochus met een diameter van meer dan 7mm 
een indicatie zijn voor slechtere behandelingsresultaten van ESWL. 
Hoofdstuk 7 geeft een overzicht van de literatuur met betrekking tot percutane 
technieken voor de behandeling van galsteenlijden. Eerst worden de technische aspecten 
van percutane cholecystostomy beschreven. Hierna worden de mogelijkheden en 
beperkingen besproken van de op dit moment beschikbare technieken voor percutane 
vergruizing en verwijdering of oplossing van galblaasstenen. 
Hoofdstuk 8 heeft betrekking op het probleem dat hernieuwde galsteenvorming na een 
niet chirurgische behandeling van galblaasstenen kan optreden. Een methode ter 
voorkoming hiervan is de chemische ablatie van de galblaas d. m. v. percutane toediening 
van scleroserende stoffen. 
Een Speciale balloncatheter werd door ons ontwikkeld om de ductus cysticus tijdens de 
sclerotherapie tijdelijk af te sluiten. De veiligheid en effectiviteit van de methode werd 
onderzocht bij varkens. De balloncatheter functioneert goed en de gevolgde methode is 
veilig, hoewel het niet lukte om een volledige ablatie van de galblaas tot stand te 
brengen. De gevolgen van het achterblijven van resten niet vernietigde galblaasmu-::osa 
op langere termijn dienen nog nader te worden bestudeerd. 
Hoofdstuk 9 bespreekt de resultaten van de studies beschreven in de hoofdstukken 2,3 
en 4 en recent gepubliceerde gegevens. Een radiologisch protocol ten behoeve van 
diagnostiek en selectie van patienten verdacht voor galsteenlijden wordt gegeven. Tot 
slot wordt een stroomschema van dit protocol gepresenteerd. 
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